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SUMMARY
This thesis is concerned with a study of the stability of salbutamol 
sulphate in aqueous solution together with the effect on its stability, 
of syrup formulation excipients.
The work necessitated the development of a stability indicating 
assay. This comprised a preliminary separation on ion-exchange material 
followed by reversed-phase, ion-pair HPLC assay. A comparison of 
this technique with the BPC indoaniline colorimetric assay revealed 
that the latter method seriously overestimates the salbutamol content 
of degraded solutions.
The degradation of salbutamol sulphate in aqueous solution was 
studied using pH-statting for pH control in order to avoid the use 
of buffer salts. The breakdown of the drug was shown to be oxygen 
sensitive and to increase with drug concentration. However ionic 
strength did not affect the rate of breakdown.
The pH stability profile of the drug showed a region of minimum 
stability around pH 9 and maximum stability between pH 3 and pH 4.
The slow rate of breakdown in this region precluded a detailed study, 
but it was shown that the degradation is not a simple acid or base 
catalysed reaction. Buffer salts were unpredictable in their 
effects, acetate stabiliing the drug whilst phosphate accelerated 
the breakdown.
The effect of sugars was studied at both pH 7.0 and pH 3.5.
Glucose accelerated the degradation of salbutamol sulphate at
pH 7.0 but sucrose had no effect, whilst at pH 3.5, glucose, 
fructose and sucrose increased the degradation rate to similar 
extents. This was ascribed to hydrolysis of sucrose at the 
more acidic pH, liberating the monosaccharides with a potentially 
"free" carbonyl group. Such a functional group is not 
available in sucrose because it is utilised in the glycosidic 
bond.
Further studies to elucidate the nature of the interaction 
involved the use of glyceraldehyde, glyceric acid, 5-hydroxy- 
methylfurfural and polyhydric alcohols. Attempts were also 
made to isolate and identify the major breakdown products but 
since these were unstable definitive identification was not 
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Salbutamol is a sympathomimetic drug which acts almost 
exclusively on adrenergic receptors. It has a stimulant 
action, producing bronchodilatation without markedly affecting the 
cardiovascular system which is controlled principally by 3  ̂
receptors (2-5). The discovery that these two pharmacological 
actions could be separated (6) allowed specific drugs to be 
developed for the treatment of cardiovascular conditions such 
as hypertension and bronchial disorders like asthma. Practolol 
was one of the first cardio-selective drugs (7) and salbutamol 
an early bronchio-selective (8,9).
Before the introduction of salbutamol in 1969, isoprenaline 
was the major drug used in the treatment of asthma. However its 
usefulness was limited by the pronounced tachycardia which it 
causes in many patients. Salbutamol, therefore, was rapidly 
accepted as the drug of choice for most asthmatics and conse­
quently has been formulated into virtually all types of pharma­
ceutical product . Inhalation aerosols provide rapid relief 
during an asthmatic attack, whilst maintenance therapy can be 
sustained using tablets or syrup. A crisis of status asthmaticus 
can be treated by parenteral administration of the drug or by 
inhalation of the nebulised respirator solution. The selectivity 
of salbutamol for receptors has led to its use in the manage­
ment of premature labour when it is generally administered as 
an intravenous infusion.
3.
Salbutamol therefore provides a good example of the complex­
ities of pharmaceutical formulation and stability testing. The 
wide range of products must all have a realistic shelf life under 
all likely storage conditions including those encountered over­
seas. Foreign markets often require modified formulations for 
reasons of stability, législation or simply local preference 
and so the stability testing of their products is a major con­
cern of all pharmaceutical companies.
1.2 Stability Testing
The intrinsic stability of any drug is assessed at an early 
stage of its development within the company but this does not 
necessarily bear any relationship to the stability of the final, 
formulated product. Skilful formulation can significantly 
increase the shelf-life of an unstable drug, but the reverse 
situation can also occur, resulting in the rapid degradation of 
an otherwise stable drug. - A common cause of this is the 
inadvertant incorporation of trace metal ions which then catalyse 
oxidative processes. These ions may be present as contaminants 
in an excipient or may originate from equipment used in the 
handling of the product. This problem has been encountered 
with several drugs including prednisolone (10), adrenaline 
(11, 34), labetalol (12) and salbutamol itself (12) . Loss of 
stability may also result fran a more specific interaction between 
drug and excipient and this too has been reported on several 
occasions (13-17) .
The stability of a pharmaceutical product may be assessed 
under three main aspects, namely, microbiological, physical and
chemical. Microbiological considerations require the prevention 
of microbial growth and may be tackled in a variety of ways, 
depending on the nature of the formulation. Some dosage forms, 
including eye drops and all parenteral formulations, must be 
supplied in a sterile condition, but unless they are packaged 
in single-dose units, a suitable preservative must also be 
included to prevent the growth of micro-organisms which may be 
introduced during the use of the product. Similar precautions 
must be taken with products such as oral liquid preparations 
and topical creams which will be used repeatedly and could 
provide a suitable environment for microbial growth.
Physical instability may manifest itself in a variety of 
ways which include precipitation, phase separation, caking, 
changes in crystal form and changes in dissolution rate. In 
the case of solution formulations, the most common physical 
changes are precipitation and colour changes. Both of these 
should be easy to detect although their prevention may not be 
so straightforward. In practice, the chemical stability of 
these formulations tends to present the biggest problem and so 
receives the most attention. Chemical stability is primarily 
concerned with the potency of the drug itself although the other 
ingredients must also be stable under reasonable conditions of 
storage and use. h well planned stability test will not only 
assay the active ingredients but also monitor the appearance 
of breakdown products which may require identification and 
toxicological study in order to verify that they do not pose 
a threat to the patient.
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All three aspects of stability are commonly assessed by means 
of accelerated storage tests. These subject the solid drug, its 
solution or formulated product to more extreme stresses than 
would be encountered in normal storage. For example, microbial 
challenge testing, high temperatures, high humidity and high 
intensity lighting may be used over a short time to mimic the 
effects of less severe stresses over a long time. Such tests 
can provide much useful information but their results need to be 
interpreted with care. Under extreme conditions reactions may 
be initiated which would not normally be encountered. For 
instance, many chemical reactions proceed via an "activated 
complex", which has a much higher energy level than either the 
reactants or the products. Considerable energy, often in the 
form of heat, must be supplied before this intermediate can be 
formed. High temperature storage tests could provide this 
energy in some cases, where normal storage would not, and so 
lead to erroneous conclusions about the stability of the compound 
in question. In the case of formulated products, extra care 
is needed since the stability of the excipients may be affected 
to a different extent from that of the drug. If an excipient 
degrades much more rapidly relative to the drug than it would 
under normal conditions, a totally different system may result, 
producing a different spectrum of breakdown products.
For these reasons, preformulation stability studies on the 
raw drug or simple solutions are usually conducted at higher 
temperatures and under more extreme stresses than studies on 
the formulated product. The information gained in the early 
work, such as the order of reaction, reaction pathways and the
effect of temperature, can then guide the interpretation of the 
full stability trials.
Pharmaceutical stability is affected by the same factors 
and conditions which influence chemical reactions in general, 
the most important ones being temperature, pH, light and humidity.
The relative importance of each of these will depend on the 
nature of the product and of the drug.
Temperature is always a major factor and elevated temperatures are 
widely used for accelerated storage tests.By establishing the relationship 
between the rate of breakdown and temperature/ is possible to 
make predictions of a product's stability at room temperature 
after conducting short-term tests at higher temperatures. This 
is commonly achieved by means of isothermal experiments and the 
Arrhenius equation (Section 1.3), although non-isothermal methods 
have been advocated (18-20) and at least one group of workers 
has developed a nonisothermal-isothermal technique (21).
Light can initiate degradative processes by exciting drug 
molecules to a higher energy state. The additional energy so 
acquired may enable the molecules to overcome the energy barrier 
of the reaction and so chemically degrade. In many cases the 
process, once initiated, can continue in the dark. This is 
known as autoxidation and is a characteristic of many natural 
products such as oils, fats and waxes. The reaction is able to 
continue in the absence of light because reactive species such 
as free radicals are produced and these perpetuate the breakdown.
Such reactions are easily prevented by packing the product in 
an amber-glass bottle or keeeping it in the dark.
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The effect of pH is much more complex and a simple relation­
ship between pH and stability does not always exist. Chemical 
reactions may be acid,water or base catalysed and the state 
of ionisation of the various chemical entities also plays an 
important role. Phenols, for instance, are much less stable in 
alkaline solutions, when they are present as the highly 
reactive phenoxide ion, than in acidic conditions where they 
are unionised (22).
Humidity is important when considering dry products such 
as powders, tablets, capsules or syrup granules which are re­
constituted before use. Powder flow properties, taiblet hard­
ness and friability, and dissolution rates in general are easily 
affected by the level of moisture in the atmosphere. Moisture 
can also lead to hydrolysis, a common mechanism of drug break­
down and in sensitive products a small increase in moisture 
content can cause considerable loss of drug potency. Hydrolysis 
of less sensitive drugs can often be kept to a minimum by 
careful selection of a suitable pH although this may be 
restricted by the physiologically acceptable pH range for the 
type of product. Eye drops and intramuscular injections, for 
example, can cause severe discomfort if they are far removed 
from physiological pH and should, ideally, be buffered to pH 7.4. 
Pharmaceutical formulation is therefore influenced by many, 
often conflicting considerations which must be carefully balanced 
before an acceptable, stable product can result.
1.3. Reaction Kinetics
Stability studies involve the measurement of rates of
reaction and their comparison under varying conditions.
For the general reaction;
aA + bB ---- > cC + dD
the rate of reaction may be determined by measuring the loss of 
reactants from the system or the appearance of products. The 
actual numerical value of the rate will depend on the component
. . , - d W  - d H  dfc] dCo]measured and may be expressed as or — 7—^ dt dt dt dt
where represents the concentration of species A, etc. and t 
is time. It is inconvenient for the rate to be dependent on 
its method of determination, but by introducing the stoichiometry 
of the reaction into the expressions, the rate can be rendered 
independent of the component studied.
i.e. 1 dfA] 1 d[B) 1 d [c l _ 1 d[D]rate = — —  ■ ■ ■ =— —  ■■— ■■ = —  ■— — —  ■a dt b dt c dt d dt
An alternative view of reaction rate is to regard it as a
function of the concentration of all the reactants. Thus, for 
the general reaction above.
Rate = k[A]°̂  where k = rate constant
a is called the order of reaction with respect to A and B the 
order with respect to B. The overall order of reaction, 
n = a + 3 . In many cases a = a and 3 = b and the order is 
said to be the same as the molecularity of the reaction.
However, this is not always the case, particularly in complex 
reactions which proceed in stages or where the solvent 
participates in the reaction but does not effectively change 
in concentration. The order of reaction must therefore be 
determined experimentally and not assumed from the stoichiometry 
of the reaction. In simple reactions n has an integral value
seldom greater than 2. Zero order reactions, where the rate 
is a constant, independent of reactant concentration, are 
sometimes encountered in gas phase reactions, particularly 
those which are surface-catalysed. Reactions in solution are 
seldom zero order, with the exception of a few enzyme-catalysed 
reactions.
First Order Reactions
In this case the reaction rate is proportional to the 
concentration of a single reactant, i.e. = kc where
C is the reactant concentration at time t and k is the rate 
constant.
This can be rearranged to
dr"- —  = kdt ... (1)
which, on integration, yields
InC - InC = kt where C = concentration o o
at zero time
A graph of InC against t is therefore linear with a slope of -k*
Second Order Reactions
A reaction may be second order in one of two ways. It may
be second order with respect to one reactant, i.e.
'’r 2- ^  = kC ... (2)dt
or it may be first order with respect to two different reactants, 
i.e.
In the first case, dC- —  = kdt
C
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integrating, | - i  = kt ...(3)
o
A plot of JL against t is therefore linear with a gradient equal 
G
to k.
The second case is more complicated
A + B  ^ products
Let the initial concentrations of A and B be a and b • respectively, 
and let x be the amount of each to react in time t.
dx = k(a-x) (b-x) —  (4)dt
Integration of this equation produces
1 Inb (a-x)k = t(a-b) a(b-x)
The situation is simplified if a and b are equal, that is the 




A further simplification is achieved if one reactant is present 
in sufficient excess that its concentration does not effectively 
change over the course of the reaction. The kinetics then 
approximate to first order with respect to a single reactant.
The resultant rate constants are termed pseudo-first order.
Higher orders of reaction are possible but are seldom en­
countered. It is much more usual for the overall reaction order 
to be non-integral due to the complex nature of the reactions 
occurring in the system. This is particularly common in 
oxidation processes where free radicals are often involved
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(Section 1.4), although oxidations are sometimes claimed to be 
zero-order (23). It has been assumed, so far, that only one 
reaction takes place between the reactants but in practice 
several reactions may be possible and the products may then 
react further. This leads to a situation where consecutive, 
parallel or opposing reactions need to be considered. In order 
to apply detailed kinetics to such systems, the various compon­
ents need to be measured independently. This requires knowledge 
of the nature of both reactants and products as demonstrated 
by the following pair of reactions.
A + B ---- 1 > C + E
A + C ---^ ^  D + E
[c l
# =  -k,[A][Bl
# =  k,WH -k̂ MCcl 
# =  k , M H
Detailed theoretical treatments of both simple and complex 
reaction kinetics can be found in the standard texts on 
chemical kinetics (24-26). However, in many pharmaceutical appli­
cations the nature of the products is not known and so only 
elementary kinetics can be applied.
Determination of Reaction Order
The simplest possible expression is always desirable and 
so first or second order kinetics should be applied initially 
to test whether they adequately describe the system. The easiest
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way of doing this is to plot a graph of In C against t (first 
order) or 1/C against t (2nd order). If a linear relationship 
down to at least 25% residual concentration is found in either 
of these cases, the relevant kinetics can be applied although 
this result should be confirmed by performing experiments with 
different starting concentrations. For instance, a true first 
order reaction will have the same rate constant regardless of 
the initial reactant concentration. However, if, as often 
happens, the graph is not linear, the reaction orders must be 
determined by alternative means.
One method is to determine the half-life of the reaction 
at different starting concentrations. The half-life is the 
time taken for the concentration to fall to half its initial 
value. It can be shown (25 ) that
and therefore t, « ^^ 2̂ n-l)
pt^ = — where P = proportionality constant
. . log t^ = log P - (n-1) log a ...(7)
A graph of log tĵ  against log a should therefore be a straight 
line of gradient (1-n). If the graph is non-linear, a change 
of order with concentration is indicated, caused by a change 
in reaction mechanism.
An alternative approach is that of van't Hoff's differential 
method
Rate = kC^ 
log(rate)= log k + nlog C
13
The rate at different concentrations may be measured by taking 
tangents to the concentration-time curve of the reaction. The 
logarithms of these values may then be plotted against log C to 
give a graph of slope n. Again, the method assumes that the . 
order remains constant irrespective of reactant concentration.
Other, more complex methods have been derived but they 
tend to require a full knowledge of the reaction products, a 
situation which is seldom possible in pharmaceutical applications, 
Even when the reaction under investigation is found to have a non­
integral order, the reaction often appears to follow simple 
kinetics over at least the first one or two half-lives and rate 
constants can be calculated on this basis. For example, many 
reactions produce a reasonably linear semi-logarithmic plot 
even though they are not truly first order. The rate constants 
calculated frcan this treatment are therefore only apparent first 
order constants but provide a useful means of comparing reaction 
rates.
Effect of Temperature
An increase in temperature frequently causes a very marked 
increase in reaction rate. This effect is described by the
Arrhenius relationship (Equation 8)
k = ... (8)
where A = constant (frequency factor) 
E^= activation energy 
R = gas constant 
T = absolute temperature
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The frequency factor. A, is a constant related to the number of 
molecular collisions occurring and leading to reaction.
A similar expression (Equation 9) has been derived from a 
thermodynamic approach, using the activated-complex or transi­
tion state theory of reaction rates
RT AS*/R -AH*/RT k = e e ...(9)
N = Avogadro's number 
h = Planck's constant 
As*= standard entropy of activation 
AH*= stcindard heat of activation 
Bu nnett (27) has developed the theory to produce expressions for 
AH*, AS* and AG*, the heat, entropy and free energy of activation 
respectively. He has demonstrated that in practice AH* and 
E^ are very similar in value but some workers prefer to use the 
thermodynamic parameters, which are more relevant to complex 
reactions (28).
The principal difference between the collision and transi­
tion-state theories of kinetics relates to the complexity of 
the reactants. In the simpler, collision theory, molecules are 
believed to react if they collide with sufficient energy. Not 
all collisions will reach this threshold energy level and so 
only a fraction of collisions actually results in chemical 
reaction.
This theory works well for simple molecules such as hydrogen 
iodide but when the reactants are more complex the theory predicts
15.
higher reaction rates than are observed. This is due to the 
fact that orientation plays a major role in these reactions 
and the energy of the molecules must be correctly distributed 
over the various bonds before reaction will take place. The 
transition-state theory developed from this and it proposes 
that a chemical reaction between two or more molecules proceeds 
via an activated complex which then breaks down to form the 
reaction products. This complex has a higher free energy than 
normal molecules and has only a transitory existence. The 
activation energy of the reaction is then defined as the 
difference in energy between the activated complex and the 
reactant molecules (24-27).
The application of reaction kinetics can therefore assist 
the formulatory pharmacist to devise a stable product. However, 
this approach can only be used to the best advantage when the 
mechanism of drug breakdown is known and this is seldom the case 
during the early development of a new drug. In this situation, 
useful information can often be gained from well known, 
chemically related compounds.
1.4 Stability of Adrenaline and Other Sympathomimetic Drugs
Salbutamol is structurally related to adrenaline and the 
catecholamines although the catechol group has been modified 
in salbutamol, making it a saligenin derivative (Fig. 1).
Apart from altering the pharmacological activity of the molecule, 
this modification also confers greater chemical stability on 
the compound, compared to the catecholamines. The catechol 











H O -(\ yCHCHgNHg
Noradrenaline
CHgOH 
H O - f  yC H C K N H C M e,
HO Salbutamol
H O -/ VcHCH^NHCHMe.\\ //
'— ' OH
Isoprenaline
Fig. 1. Catechol, saligenin and some biologically active 
derivatives.
17,
characterises both the natural conpcunds, adrenaline and nor­
adrenaline, and the synthetic drugs such as isoprenaline.
Aqueous solutions of adrenaline quickly acquire a pink colour 
on standing and this has been the subject of considerable 
research (29-35) as well as posing a formidable problem for 
pharmacists wishing to prepare acceptable adrenaline formulations 
for medicinal use.
Oxygen plays a major role in the degradation of adrenaline 
and similar catecholamines, and oxygen uptake has often been 
used as a means of following the course of the reaction (11,
36) . The nature of the oxidation products formed from adrenaline 
varies with the pH of the solution. In alkaline solution, oxygen 
uptake is accompanied by the production of a transient yellow- 
green fluorescence due to adrenolutin
which rapidly disappears leaving a yellow, then turbid brown 
solution (29). At pH 6-8 the solution turns red on exposure to 
air after a preliminary induction period and then darkens due 
to the formation of polymeric melanins (29). Chaix et al. (11) 
have proposed that this reaction is catalysed by heavy metal 
ions. In the absence of added metal ions they found that 
oxygen uptake by adrenaline solutions was very low and suggested 
that this uptake was due to trace metal contamination. However, 
at pH5, true autoxidation in the absence of metal ions has been
18.
demonstrated by Sokoloski and Higuchi (37) who added potassium 
cyanide to the reaction mixture, to complex heavy metals.
Most metal ions, particularly copper, have been shown to 
catalyse the oxidation of adrenaline (11,34-37) but iron appears 
to have a unique role. Inorganic ferric ions alone form a 
stable violet complex with adrenaline which does not oxidise 
further at pH 7 (11) but in the presence of EDTA efficient 
catalysis of adrenaline breakdown occurs (38). Formation of 
a stable ferric-EDTA complex was proposed, comparable to the 
natural iron-protein complexes like ferritin or ferricytochrome 
found in biological systems.
The probable mechanism of adrenaline oxidation under these 
conditions is given in Fig. 2 (29-31). The red colouration 
which develops is due to adrenochrome, which itself catalyses 









The reaction sequence is believed to be mediated by free 
radicals since a lag time is demonstrated followed by a first 
order relationship (28). At lower pH, Sokoloski and Higuchi 
did not detect a lag phase but suggested that this was due to 
the increased reactivity of the intermediate radical. They 
concluded that none of the gross oxidation products had a 
significant catalytic effect (37).
Studies on related compounds such as catechol, 3,4-dihydroxy- 
cinnamic acid and noradrenaline indicated that although rates of 
reaction may vary, (noradrenaline was found to be more stable 
than adrenaline), the free energies of activation (AG* values. 
Section 1.3) were almost identical (28). They inferred from 
this that the nature of the reaction in each case is the same 
but side-chain variations cause differences in solvation, 
protonation etc., which influence the rate of reaction.
Studies on phenylephrine by El-Shibini, Daabis and Motawi 
led them to the conclusion that this drug can also cyclise in 






Under acidic conditions, degradation was found to be too slow 
for convenient study. Further investigations (40) demonstrated 
that copper has a strong catalytic effect on the reaction but 
that iron has virtually no effect. Unfortunately they did not 
examine iron together with EDTA to confirm a parallel with the 
results of Green, Mazur and Shorr (38), although they did show 
that EDTA prevents the catalytic action of copper. The reduced 
rate of breakdown of phenylephrine relative to adrenaline is 
due to the loss of one phenolic hydroxyl from the benzene ring 
and reflects the lower reactivity of phenol compaired to that of 
catechol.
Although the synthetic sympathomimetic drugs have been widely
available for many years, very little data on their stability
has been published. Salbutamol in particular has been the
subject of only one published stability study which was of
limited scope and used fluorimetric and colorimetric assays (41).
The work was designed to determine the stability of salbutamol
solutions under conditions of hospital use, particularly in
relation to intravenous infusion therapy. Phosphate buffers
over the pH range 6.9 to 8.3 were used, as well as 5% dextrose
solution, a common vehicle for intravenous medication. Solutions
under investigation were sealed in over-sized ampoules and
o ostored at temperatures ranging from 40 to 70 . Pseudo-first 
order rate constants were calculated although in many cases 
the graphs showed marked deviations from linearity. Arrhenius 
plots were found to be non-linear and the authors inferred that 
there was a change in reaction mechanism above 60°. They 
concluded that salbutamol was considerably more stable in dextrose
21.
solutions than in solutions of near neutral pH and that salbutamol 
solutions should not be heat sterilised. .Related compounds 
















The bitolterol study was concerned purely with the rate 
of hydrolysis of the ester linkages and it was found that 
reduction of the dielectric constant with non-aqueous solvents 
considerably increased the shelf-life of the solution (43) . 
Carbuterol differs from the catecholamines by degrading 
significantly under anaerobic conditions (44). The main 
objectives of the published investigation were to define the 
kinetics of the breakdown under such conditions and to identify
22.
breakdown products. The major degradation product was isolated 





Pseudo 1st order kinetics were followed, with catalysis by 
phosphate buffers.
Pirbuterol, the compound most closely related to salbutamol, 
was found to fdllow 1st order kinetics during its breakdown 
at pH 7 and 90° (42) and the major breakdown product was identi­
fied as 2-hydroxymethyl-3-hydroxy-6-formylpyridine. A full
H O H ^ ' ^ N ' ^ C H O
2-hydroxymethyl-3-hydroxy-6-formylpyridine
pH-stability profile was produced (pH 1-14), the drug showing 
a point of minimum stability at pH 8 but no pronounced point of 
maximum stability. Unlike other studies, the data was obtained 
without the use of buffers, the pH of the test solution being 
periodically adjusted by the addition of acid or alkali.
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1.5 Oxidation
Since oxidation plays an important role in the degradation 
of catecholamines and related compounds (Section 1.4) it is 
important to consider the factors which affect this particular 
type of reaction.
Oxidation is defined as loss of electrons and so molecular 
oxygen need not be involved at all. However, in many pharma­
ceutical systems, oxygen is readily available and becomes incor­
porated into the reaction mechanism. These reactions are 
often mediated by free radicals, produced by the action of heat 
or light and are therefore self-propagating. A typical chain 
reaction may be demonstrated by considering a drug, RA
RA — > R* + A* Initiation
R- + O^— + RO^'
RO^ + RA > ROOA + R' Propagation
ROOA > RO" + -OA
R0» + A* ---> ROA Termination
The free radical nature of these reactions results in complex 
kinetics and the overall process has a non-integral order 
(Section 1.3). The reactions are often catalysed by heavy metal 
ions which can increase the rate of free radical production.
Other oxidations are catalysed by hydrogen or hydroxyl ions. 
The hydroquinone-quinone reaction is a typical example of this 
type of redox system and plays an important role in the degrada­
tion of adrenaline (Section.1.4). Quinones are usually coloured 
compounds whilst hydroquinones are colourless and so oxidation 






It may be predicted from the redox equation that oxidation will 
be minimised in acid solutions. This is often true in the case 
of pure solutions, but buffering to the required pH does not 
always solve the problem, since the buffer salts themselves 
can act as catalysts or stabilisers. Boric acid, for example, 
has been shown to stabilise catecholamine solutions (45-48) by 
chelating with the phenolic groups, whilst iron, at acidic pH 
can catalyse the oxidation (49). Such effects, coupled with 
the fact that many drug molecules have several functional 
groups which could be oxidation-sensitive, can result in ccxnplex 
pH-stability profiles (42,50).
Temperature effects for oxygen dependent processes tend 
to be unpredictable because of the alteration in oxygen 
solubility. Normally, a rise in temperature causes an increase 
in reaction rate but the accanpanying fall in oxygen solubility 
could decrease the rate of reaction.
1.6 Sugar Chemistry
Pharmaceutical syrups contain large quantities of sugar which 
not only sweeten the preparation but also increase its viscosity, 
giving the liquid "body". Because they frequently represent the
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major ingredient of such preparations, the properties of the 
sugars may have a profound effect on the properties and stability 
of the whole formulation.
Sugars are members of the class of compounds known as carbo­
hydrates. The carbohydrates are commonly sub-divided into 
sugars, oligosaccharides and polysaccharides although the boundaries 
between them are indistinct. Sugars include the mono- and di­
saccharides. Oligosaccharides generally contain up to ten mono­
saccharide units and polysaccharides are thé high molecular 
weight carbohydrates containing hundreds or even thousands of 
monosaccharide units.
Most monosaccharides,particularly the ccxnmon ones, contain 
five or six carbon atoms although some may have as few as three 
and others as many as seven. Many monosaccharides occur 
naturally as metabolic products of living organisms. In general, 
they have a sweet taste and are soluble in water, making them 
popular as flavouring agents in food and drinks as well as 
pharmaceuticals.
The commonest sugars are polyhydroxy aldehydes or ketones 
and are optically active, due to the presence of several a - 
symmetric carbon atoms (Fig. 5). Glucose and fructose are 
examples of an aldohexose and ketohexose respectively. The 
"hexose" portion of the name refers to the number of carbon 
atoms in the molecule (six in this case), and the keto- or aldo- 
prefix defines the nature of the carbonyl group. It can be seen
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CHO CH,OH
OH 0 = 0
H O % -H  HO-C-H
H -^-O H  H % -O H
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that both these sugars can have several isomers which vary in 
the configuration of the hydroxyl group at each asymmetric centre, 
These isomers represent different chemical entities and include 
the sugars galactose and mannose amongst others (Fig. 6).
ÇHO ÇHO
H O -C -H  H -C -O H
H O -C -H  HO -C-H
H -C -O H  H O -C -H  Galactose
H—C—OH H“C“"OH
CH.OH ^  CH.OH
The sugars in Figs. 5 and 6 have been drawn as straight-chain 
compounds since this makes it easier to identify the asymmetric 
centres and to appreciate the relationship the isomers bear to 
each other. In fact, the molecules usually exist as cyclic 
structures by forming internal hemiacetals with an additional 
asymmetric centre (51). The most common way of representing this 
is by fi- Haworth formula as shown in Fig. 7. This is only a 
diagrammatic representation since the rings are not really 
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J&T new asymmetric carbon atom
Fig. 7
Some sugars, such as fructose, form five-membered rings and are 
therefore termed furanose instead of pyranose which defines the 
ring as six-membered. The new asymmetric carbon atom is called 
the anomeric centre and the a and 3 forms are known as anomers.
In aqueous solutions the three forms of the sugar (a and 3 
rings and the acyclic structure) exist in dynamic equilibrium 
with each other. The percentage in the open form at any time 
is less than 0.5% (52) but the addition of a reagent which 
displaces the equilibrium by reacting purely with the aldehyde 
form, causes rapid and complete conversion to this structure (53)
The most reactive site in sugar molecules is the carbonyl
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carbon atom; the hydroxyl groups can be methylated or acetylated 
relatively easily, but most important reactions occur at the 
carbonyl group. Isomérisation can take place easily at this 
point, particularly in neutral or basic solutions, via an 
enediol structure. This is known as the Lobry de Bruyn-van 
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This isomérisation is the cause of the formation of mixed products 
in many reactions involving sugars and so, for improved yields, 
it is often recommended that reactions be performed under acidic 
conditions, where possible. In the case of glucose, the re­
arrangement leads to the generation of fructose and mannose.
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In neutral or alkaline solution, sugars are readily oxidised 
by molecular oxygen with loss of formate. This produces an acid 
















70% yields of arabonic acid have been obtained from glucose by 
carrying out the reaction in IN potassium hydroxide solution (54) 
and the method has been used to prepare other aldonic acids from 
the relevant sugars (55).
In acidic solutions the monosaccharides are much more stable, 
most of them showing maximum stability around pH 3 to 4 (56-58). 
Small amounts of disaccharides may be formed by dehydration be­
tween two monosaccharide units but the reaction is seldom of 
any practical significance. Stronger acids cause intramolecular 
dehydration with the formation of furan derivatives (Fig. 9).
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The product of the reaction depicted in Fig. 9, 5-hydroxymethyl- 
furfural, has been implicated in many sugar reactions, partic­
ularly those involving the breakdown and discolouration of 
sugar solutions (58, 59).
Other reactions at the carbonyl carbon include glycoside 
formation with alcohols and glycosylamine formation with 














No acid catalyst is needed for the amine reaction, unlike the 
méthylation, and it has been suggested (60) that the acyclic 
form of the sugar is involved. Both glycosides and glycosyl- 
amines are hydrolysed back to the free sugars by aqueous 
acids (60, 61).
The carbonyl group is readily oxidised by a variety of
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oxidising agents, in addition to the oxidation in alkaline solution 
previously discussed. Mild oxidation with bromine water yields 








More powerful reagents, e.g. nitric acid, attack both ends of 
the molecule producing an aldaric acid.
CHO CO,H
CH,OH C O j H
Glucose Glucaric acid
Reduction of the carbonyl yields a polyhydroxy alcohol or alditol
Glucose may be reduced to sorbitol using sodium amalgam or
sodium borohydride.
CHO CHgOH
(CHOH)^ -  > (iHOH)^
C H j O H CHgOH
Glucose Sorbitol
Alditols are more stable than their corresponding sugars since 
they lack the reactive carbonyl. They are also unable to form. 
cyclic structures in solution. They can be oxidised to sugars 
by hydrogen peroxide in the presence of ferrous salts but are 
unaffected by dilute acids and alkalis.
Disaccharides are formed by loss of water between two 
monosaccharide units. This reaction involves the anomeric
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centre in at least one of the units but the other monosaccharide 
may retain a free carbonyl group and therefore its reducing 
properties. Maltose is an example of such a sugar, being 
composed of two glucose units joined through the 1,4 positions:
C H j O H CHjOH
.ffree carbonyl 
positionw  y  , |T U M
OH
Maltose
Sucrose, on the other hand is a non-reducing sugar, because both 




Unlike maltose, a sucrose molecule contains two different 
monosaccharide residues. It is, in fact, a glucosyl fructose 
and may be hydrolysed with dilute acid to yield equal quantities 
of glucose and fructose. This hydrolysis results in a change 
in optical rotation of the solution from positive to negative 
and the process is therefore often called inversion. The reason 
for the change is that fructose is more strongly laevorotatory 
than glucose is dextrorotatory. The chemical properties of 
the disaccharides are determined largely by their constituent 
monosaccharide units but reactions involving the carbonyl group 
are impossible in sugars such as sucrose without prior hydrolysis,
Polysaccharides include substances such as starch and
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cellulose which are naturally occurring plant storage and 
structural polysaccharides respectively. Like the di- and oligo­
saccharides, they can be hydrolysed to their component units by 
dilute acids. Specific enzymes exist which can selectively 
hydrolyse certain linkages whilst leaving others intact and use 
of these has proved of great value in structural determinations 
on these complex molecules.
Semi-synthetic cellulose derivatives have been prepared from 
purified natural cellulose by the use of various reagents. The 
objective is to modify the properties of the compound by re­
placing some of the hydroxyl groups with, for example, methoxy 
or acetyl groupings. The modified celluloses are used quite 
commonly in pharmacy for a variety of purposes. Many tablet 
film coatings consist of cellulose derivatives such as hydroxy- 
propylmethylcellulose. Methylcellulose and carboxymethyl- 
cellulose are used as thickening agents and laxatives (62).
Cellulose itself is not soluble in water but the semi­
synthetic derivatives are slowly soluble, forming viscous liquids 
or gels. They are available in different grades with fairly 
well defined properties so that a suitable product for a given 
purpose can be readily selected.
1.7 Interactions Between Drugs and Syrup Excipients
By far the major component of pharmaceutical syrups is 
sugar of some kind. Glucose and sucrose are probably the most 
popular but sorbitol is also used quite widely (63). Other 
important ingredients include preservatives and antioxidants
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together with flavourings,colourings and buffer salts.
Although it is now well known that buffer salts and 
stabilisers such as EDTA can affect drug stability (Sections 
1.4 and 1.5) sugars and carbohydrates, when used in pharma­
ceutical preparations, are usually regarded as inert and their 
interactions with drugs have seldom been investigated. Penicillins 
have received some attention because they are frequently added 
to intravenous infusions containing glucose, and it has been 
shown that glucose and fructose accelerate their breakdown at 
neutral and alkaline pH (64 - 68). With reference to oral 
formulations, sucrose has been found to affect penicillin in­
activation, again in neutral or alkaline solutions (64, 69).
The mechanism of the sucrose-benzylpenicillin reaction has been 
investigated by Bundgaard and Larsen (13) and they showed that 
an ester is formed between the penicillin and sucrose. This 
ester then hydrolyses to produce benzylpenicilloic acid. The 
rate of ester formation and hydrolysis was considerably greater 
than the rate of direct penicillin hydrolysis to benzylpeni­
cilloic acid and so a catalytic effect was observed.
Kitson et ai. (16) have investigated the effect of sugars 
on the stability of the drug 2-amino-6-methyl-5-oxo-4-n-propyl- 
4,5-dihydro-l,2,4-triazolo|l,5-aJ pyrimidine. Both reducing
CH
N
O ^ N ' ^ N ' ^ nh
C H j C H j C H j
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and non-reducing sugars were examined and the former were found 
to result in the least stable systems. However, in the presence 
of oxygen, terminal alcohol groups of non-reducing sugars were 
believed to be oxidided to aldehydes, allowing reaction to take 
place as before. The mechanism they proposed involved the 
formation of Schiff bases by reaction between the amino group 
of the drug and the aldehyde of the sugars.
1 2  1 2 1 2  R CHO + R NH^ > R CH(OH)NHR ---> R CH=NR + H^O
Later work by the same authors (17) revealed that methanol and 
acetone did not react but acetaldehyde caused considerable loss 
of drug. This provided some confirmation for the proposed 
mechanism. However acetone would also have been expected to 
react, as sorbose, a keto sugar did. This anomaly can be 
explained if the keto sugars undergo the Lobry de Bruyn-van 
Ekenstein rearrangement under the alkaline conditions of the 
experiment, to yield the corresponding aldo sugars which are 
able to react by the proposed mechanism.
Other pharmaceutical excipients have been found to interact 
with drug molecules. A prime example is metabisulphite which 
is often used as an antioxidant to stabilise oxygen-sensitive 
formulations. Adrenaline is a particularly oxidation-prone 
drug (Section 1.4) and anything which removes oxygen from the 
formulation would be expected to increase its stability. 
Unfortunately, adrenaline reacts specifically with metabisulphite 
and the reaction has been studied by Schroeter and others (14,
15, 47, 48, 70). The mechanism they proposed involves nucleo- 
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S O 3H
Ephedrine and other compounds which lack phenolic hydroxyls 
were found not to react, although synephrine did react.
CHCHNHCHI I
^ ^  O H C H 3
Ephedrine
C H C H j N H C K
Synephrine
Phenolic hydroxyls in the meta position failed to activate the 
molecule to the reaction and compounds without a hydroxyl on the 
a-carbon atom were also unreactive.
Some Japanese workers have recently patented a method of 
avoiding this problem (71). They stabilised ampoules of adrenaline 
injection by adding 4% reducing sugars to the solution. Glucose, 
galactose, fructose, maltose and lactose were all tested and 
it is claimed that after heating the ampoules, the stabilised 
injections retained more than 87% adrenaline whilst a control 
had none at all. This suggests that the limited quantity of 
oxygen available in the sealed ampoules, preferentially oxidises 
the sugars rather than the adrenaline, a useful, if somewhat 
surprising, result. Ascorbic acid has also been considered 
as an alternative antioxidant(72) but was found to produce 
hydrogen peroxide, a powerful oxidising agent.
38,
1.8 Assay of Salbutamol Sulphate
Several assay methods have been used for salbutamol, its 
salts and related compounds (Table 1). However, most suffer 
frcm major disadvantages, when applied to kinetic studies in the 
presence of large quantities of breakdown products.
Table 1. Assay techniques used in stability studies on salbutamol 
and related compounds.
Drug Reference Assay Method(s)
Salbutamol 41 Fluorimetry and Colorimetric 
Reaction
Carbuterol 44 HPLC (Cationic exchange) and 
Colorimetric reaction
Pirbuterol 42 TLC
Adrenaline 37 Spectrophotometry of derivative
Terbutaline 74 GLC and TLC
Catecholamines 28 Fluorimetry
Bitolterol 43 TLC and HPLC
Phenylephrine 39 Colorimetric reaction
Phenylephrine 75 TLC and GC
Fluorimetry and uv spectrophotometry are the two simplest
techniques. However, they are suitable only for pure solutions
of the drug, since many possible degradation products could have
similar emission or absorption spectra. Salbutamol has a
X "t 278 nm but this is primarily an aromatic absorption max j jr
characteristic of a substituted benzene ring, and so any similar 
aromatic molecule will interfere with the assay. A similar problem
39
arises with fluorimetry although it has been used by some workers 
for stability studies (41).
A colorimetric assay based on the formation of an indoaniline 
dye is used in the BPC 1973 for salbutamol inhalers (73) . The 
product under examination can be assumed to have undergone only 
a small amount of decomposition and the assay is intended mainly 
to ensure that the metering device delivers the correct dose.
It is therefore unnecessary to have a highly specific, stability 
indicating assay. The main problem with this method is that 
half the salbutamol molecule is "lost" during the reaction (Fig. 
11) and so breakdown products with modifications in this portion 
of the molecule (the amino side-chain), will be assayed as sal­
butamol. The method is therefore of little value in stability 
and kinetic studies, although it was used during the developmental 
work on sàlbutamol.
C H j O H  
H 0-^ ^^^C H C H j,N H C IV Ie3  - ( -  H ;N -^ ~ ^ N IV Ie ^
Salbutamol






A similar colorimetric reaction with 4-aminophenazone has been 
used by some workers to assay salbutamol in the presence of 
propylene glycol, sodium metabisulphite and calcium disodium 
edathamil (78).
Gas chromatography has been used in metabolic and biochemical 
studies for the measurement of drug levels in body fluids (76). 
This technique requires the drug to be derivatised, a comparable 
procedure to that used in a colorimetric reaction, and subject 
to similar potential drawbacks. Detection and measurement of 
the chromatographic peaks used mass fragmentography, an expensive 
and difficult method for routine assay work. Mass fragmento­
graphy has also been used alone for biochemical studies but 
careful extraction procedures are then necessary to separate 
endogenous compounds (76, 77).
Thin layer chromatography (TLC) is a highly versatile and 
sensitive technique which has been applied to most drugs, 
including salbutamol. It is used as a quality assurance check 
on the drug in the B.P. (79) but is not readily adapted to 
accurate quantitative work.
The only remaining technique of any relevance is high per­
formance liquid chromatography (HPLC) and this was selected 
as the most promising method of assaying salbutamol accurately 
in the presence of its degradation products. HPLC has the po­
tential to combine the resolution efficiency of TLC with easy 
quantification and so it is not surprising that HPLC separations 
have been developed for very many drugs, both in biological fluids
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and in pharmaceutical formulations. The variety of column 
packing materials now available has expanded the versatility 
of the technique tremendously and should enable any separation 
problem to be solved, given enough time, money and patiente I
1.9 HPLC Theory
There are three principal types of HPLC, adsorption, ion 
exchange and reversed phase. They vary in the nature of the 
column packing material but all rely on the same general principles 
Separation is achieved by injecting a small sample of the drug 
solution onto a packed column of the stationary phase and eluting 
the various components of the sample by pumping a suitable liquid 
mobile phase through the column. The stationary phase may be 
silica, a synthetic polymer or a modified silica which has diff­
erent functional groups bonded to the silica backbone. The 
mobile phase is largely dependent on the stationary phase but 
is usually an organic-aqueous mixture containing buffer salts 
or surfactants. The main difference between HPLC and traditional 
column chromatography lies in the particle size of the column 
packing material. HPLC uses materials with a particle size of 
5 - 1 0  ym. This means that the columns are much smaller 
(4mm I.D.) and shorter (10 - 30 cm) than traditional chromato­
graphy columns but because the small particles present a high 
resistance to flow, the mobile phase has to be pumped through 
under pressure.
Separation of the components of the mixture is dependent on 
their different relative affinities for the stationary and 
mobile phases. Compounds which are strongly adsorbed by the
42
packing material will have long retention times, whilst those 
which are readily soluble in the mobile phase will elute rapidly. 
The precise mechanism of separation varies with the packing 
material. Polar materials such as silica rely mainly on ad­
sorption, polar molecules having a high affinity for the exposed 
hydroxyl groups of the silica. Mobile phases used with silica 
columns generally contain a high proportion of organic solvent, 
sometimes with the addition of acids or bases to ensure that the 
solutes are in the desired ionisation state. This chromatographic 
mode is most useful for compounds of medium polarity. Highly 
polar molecules tend to be adsorbed so strongly that they are 
difficult to elute and hydrophobic compounds are insufficiently 
retained to enable separation to take place.
Partition plays a major role in systems where a stationary 
liquid phase is used. This is achieved by impregnating an "inert" 
solid packing material with the chosen liquid phase and is an 
extension of the technique of liquid-liquid extraction.
Ion exchange HPLC works by standard ion-exchange mechanisms, 
cationic exchangers being used to separate cations and anionics 
for anions. Both strong and weak exchangers are available and 
aqueous buffer solutions are the most usual mobile phases.
Reversed-phase packing materials are a relatively recent 
development but have rapidly become established as highly 
versatile analytical tools. They are available as chemically 
modified silicas, in which the exposed silanol groups have been 
alkylated. The most gommon modification is the octadecyl (Ĉ g)
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group which has the effect of rendering the silica hydrophobic 
instead of hydrophilic. As a result, non-polar molecules are 
adsorbed by the material and such columns originally found 
application in the separation of hydrocarbons. However, it was 
soon discovered that the addition of certain ions to the mobile 
phase enabled good separations of polar solutes to be achieved, 
due to ion-pair formation.
Although most ionic molecules separate into their constituent 
ions in aqueous solution, some large ions are more stable when 
paired with a counter-ion, enabling partition into a non-aqueous 
environment. Such a mechanism is the basis of many extraction 
procedures used, for example, in the extraction of drugs from 
biological samples. The counter-ions used in HPLC are often 
surfactants such as sodium dodecyl sulphate or cetrimide and so 
the term "soap chromatography" (80) is sometimes applied to the 
technique. The precise mechanism of the separation is not 
yet clear (81). The ion-pair may form in the mobile phase and 
then be adsorbed by the stationary phase (82, 83). Alternatively, 
the long-chain counter-ion may be adsorbed first, enabling a type 
of ion-exchange process to take place, as proposed by Knox and 
coworkers (80, 84). Recently Bidlingmeyer et al. have 
proposed a new mechanism which seems to be a mixture of the 
two (85).
The efficiency of the column can be described mathematically 
in the same way, regardless of the actual physico-chemical 
interactions involved. Several parameters are necessary in 
order to be able to compare the efficiency of different columns
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and to check on the continuing integrity of an established column.
The first important parameter, which is widely used, is the
column capacity ratio , k '. Its main use is as a retention
parameter. Each solute in a mixture will have an individual
k! value and the greater the difference in k' between two
components, the greater will be their separation.
k' = ^s 
"m
n^ = number of moles of solute in stationary phase
n = number of moles of solute in mobile phase m
In practice, n^ and n^ cannot be measured and a more useful 
definition of k' relates it to retention times which are readily 
determined from the chromatogram.
k' = ^r ^o ...(10)
to
t^ = solute retention time
t = retention time of unretained solute o
Retention times tend to vary between chromatographic systems 
due mainly to differences in void volumes and packing efficiency. 
Use of capacity ratios eliminates, this problem and enables results 
from different laboratories or different pieces of equipment to 
be compared. The ratio of k' values for two peaks in the 
chromatogram is known as the separation factor, a
k'a =  a
The other major parameter used to define a chromatographic system 
is N, the number of theoretical plates in the column. The greater
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the value of N, the more efficient the column,
N = 16 / r
w
t^ = peak width in time units
(11)
1.0
a = variance of band 
in time units2a0.607
2.354(1
t =4a w Time
Pig. 12
An alternative way of describing column efficiency is to calculate 
the height equivalent to a theoretical plate (HETP). The smaller 
this value, the greater the separating power of the column
H = HETP
L = length of column
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The concept of theoretical plates developed from an analogy 
with distillation columns (86, 87). A number of equilibria are 
considered to arise within the chromatographic column, each one 
comparable to the equilibrium which exists on a plate in a dis­
tillation column. Each "plate" represents a progressive increase 
in the resolution of the ccanponents, and so the more plates present 
in the column, the greater will be its efficiency. A typical 
10 cm column should contain around 4000 to 5000 plates.
A column with a low plate number may separate the components 
of the mixture but with such broadening of the bands as to make 
the chromatogram useless for analytical purposes. Ideally, peaks 
should be as narrow as possible with bas eline resolution between 
successive peaks but in practice this is not always possible.
A ccanpromise must therefore be reached between ideal separation 




t^ = retention time of solutes 1 and 2
t = peak width of solutes 1 and 2 w
When = 1.5 the overlap of two adjacent peaks is less than 1%
but even at R =1.0, resolution is sufficient to make the two s
peaks readily recognisable, even if one is much smaller than the 
other (Fig. 13).
Analysis times need to be kept as short as possible for two 
main reasons. The obvious one is that more samples can be processed
47.




in a given time and this is a great advantage in routine assay 
work with large numbers of samples. The other reason is that 
band broadening by solute diffusion is reduced if the analysis 
time is short. Solute diffusion is the cause of the progressive 
broadening of chromatographic peaks with time, resulting in 
sharp, narrow early peaks, but broad less distinct peaks for 
solutes with long retention times. Since it is difficult to 
accurately measure such peaks, HPLC systems tend to be developed 
so that the most important peaks elute early in the chromatogram,
Gradient elution provides a means of avoiding this problem 
with strongly retained solutes. In this case the composition 
of the mobile phase varies with time so that its elution power 
steadily increases. In this way a strongly retained compound
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can be eluted much more quickly than in isocratic HPLC where the 
mobile phase composition remains constant. The disadvantage 
is that the column has to be re-equilibrated to the starting 
composition before the next sample can be injected and so the 
overall analysis time may not be any shorter, although the 
chromatography may be considerably improved.
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Section 2. EXPERIMENTAL METHODS
A. ANALYTICAL METHODS
Materials
Salbutamol sulphate was B.P. grade and was used as supplied by 
Allen and Hanburys Research Ltd. (now Glaxo Group Research), 
without further purification.
1-(4-hydroxy-3-methylphenyl)-2-(t-butylamino)ethanol (AH 4045) 
was used as supplied by Allen and Hanburys Research Ltd., 
without further purification.
Acetonitrile and methanol were HPLC grade (Rathbum Chemicals 
Ltd.)
Isopropanol and ethyl acetate were AnalaR grade (BDH 
Chemicals Ltd.)
Sodium dodecyl sulphate was a "specially pure" grade (BDH 
Chemicals Ltd.)
Perchloric acid was AnalaR grade (BDH Chemicals)
SP-Sephadex C25 was obtained from Pharmacia Ltd.
Ammonium chloride was AnalaR grade (BDH Chemicals Ltd.)
All other chemicals, solvents and reagents were of AnalaR 
quality wherever possible.
Water was distilled in an all glass still.
Equipment
HPLC System: Pye Unicam LC3 chromatograph
Pye Unicam LC3UV variable wavelength detector
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Pye Unicam Minigrator DP88 computing integrator 
Tekman TE200 flat bed chart recorder 
10 cm stainless steel column (0.4 cm I.D.)
packed with Spherisorb S5 ODS 
Rheodyne 10 y1 loop valve 
Pye Unicam SP 1800 scanning spectrophotometer 
Pye Unicam SP 500 spectrophotometer 
Buchi Rotavapor-R rotary evaporator 
Jeol FX90Q nuclear magnetic resonance spectrometer 
Jeol JNM-PS-100 nuclear magnetic resonance spectrometer 
AEI MS12 mass spectrometer
Analytical glassware was mainly Grade A and was cleaned 
regularly with "chromic acid".
TLC plates were precoated and obtained from Anachem Ltd..
The adsorbent was silica gel G with a uv__. fluorescent indicator.254
Two thicknesses were used, 250 ym and 1000 ym (for preparative 
work).
The chromatography columns for the Sephadex-extraction of 
analytical samples consisted of glass tubing 60 cm x 0.6 cm 
I.D. fitted with a Teflon burette tap at the base.
2.1 Development of HPLC Assay
Almost every possible mode of HPLC has been used for the 
separation of catecholamines and phenethylamines as demonstrated 
in Table 2.
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HPLC Mode Packing Material Compounds Separated Ref.
Adsorption Partisil Phenethylamines 88
Spherisorb A20 Catecholamines 84
























Partisil ODS Catechol derivatives 92
Cornell C^g Antihistamines and 
antitussives 91
yBondapak:: phenyl Pseudoephedrine, 
triprolidine, chlor­
pheniramine 100
Corasil phenyl Antihistamines and 
antitussives 91






Amberlite XAD-2 Cough/COId syrups 99
Table 2. HPLC techniques used for the analysis of catecholamines 
and related compounds.
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Adsorption onto silica has been used by Jane (88) for 
a wide range of drugs including adrenergics like ephedrine. 
Cashman et al. (89) used silica and also a strong anion ex­
changer to separate amphetamines and a few other phenethyl­
amines, whilst good separation of the components of cough/ 
cold remedies has been achieved on strong cationic exbhangers 
(90). Knox and Jurand (84) used three types of HPLC for 
catecholamines and their metabolites and concluded that "soap 
chromatography" was the technique of choice, giving the 
most efficient columns and greatest sensitivity 6f detection. 
Several other workers have used reversed phase HPLC for 
similar compounds although ion-pairing with long chain surfact­
ants has not always been found necessary (9L-98).
Biological samples are usually pre-treafeed to remove 
the endogenous substances which tend to accumulate on the 
columns and shorten their useful life. A similar problem 
might be expected in the analysis of pharmaceutical syrups. 
These also contain a great many adjuvants although their 
nature is somewhat different from those compounds encountered 
in biological samples. Mohammed and Cantwell (99) succeeded 
in directly analysing pharmaceutical syrups by using a pre­
column of anionic exchange material before the main 
analytical column of nonionic resin. The precolumn retained 
unwanted substances, including colourings and preservatives, 
whilst the drugs of interest were washed onto the main column. 
The precolumn was then washed while the main column was 
being developed. Such a system requires a fairly complicated 
valve system and two solvent pumps and is outside the scope
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of many analytical establishments.
Bachman has also analysed pharmaceutical syrups by 
HPLC but he extracted the drugs by shaking the diluted syrup 
with diatomaceous earth (100). This was separated and eluted 
with water-saturated chloroform. Aliquots of this solution 
were applied to a reversed-phase HPLC column for analysis. 
Direct analysis of cough expectorants without any pre-treat­
ment has been achieved by injecting samples of diluted syrup 
onto a reversed-phase column and eluting with methanolic 
potassium dihydrogen phosphate solution (94).
In the development of a stability indicating assay for 
salbutamol, the TLC separation was taken as a starting point, 
since it is sometimes claimed that a TLC separation can be 
transferred to HPLC with very little modification to the 
mobile phase (101, 102). A 25 cm silica gel (Partisil 10) 
column was used with the TLC solvent (79) as the mobile phase. 
The detection wavelength was 254 nm and 10 yl injections 
were made via a loop valve.
The traces obtained are shown in Fig. 14. The peaks are 
quite sharp but the baseline was not stable and replicate 
injections showed a marked loss of height. Calculation of the 
plate number (Equation 11) revealed that the column efficiency 
had fallen to 25% of its starting value after four injections. 
Some separation of the components of a degraded salbutamol 
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Fig. 14. HPLC traces of 0.2% salbutamol sulphate solution 
Column: 25 cm Partisil 10
Solvent: Ethyl acetate: isopropanol:water: ammonia
(50:30:16:4)
—1Flow rate: Approx. 1.5 ml min
Detection: UV 254 nm
55
0.01 AU
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0.005 AU
L ±JL X
0 10 12 14
Fig. 15. HPLC traces of degraded 0.2% salbutamol sulphate solutions 
Time scale in minutes
A Conditions as Figure 14.
B Conditions as Figure 14 but ammonia content in solvent 
reduced to 1%.
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The high content of ammonia in the TLC solvent (4%) was 
thought to be responsible for the steady loss of column 
efficiency. Silica is unstable at high pH and so strongly 
alkaline mobile phases are not recommended for HPLC (81, 92). 
Reduction of the ammonia content to 1% produced better 
resolution of degraded samples although this was still not 
satisfactory (Fig. 15). The large negative peak at approx­
imately 9.5 minutes was due to the water present in the 
sample and could have masked additional degradation peaks.
A series of investigations were then carried out using 
mobile phases of different composition. The isopropanol was 
replaced by methanol in seme cases, to increase the polarity 
of the solvent and the ratio of ethyl acetate to alcohol was 
varied. Acidic mobile phases were also tried in an attempt 
to prevent the progressive fall in plate number which was still
Component A B
Mobile phase 
C D E F G H
Ethyl acetate 100 80 70 80 80 40 60 100
Methanol 68 88 88 - - - - lOO
Isopropanol - - - 88 88 108 98 -
Water 32 32 40 32 32 52 42 . -
0.880 ammonia 2 2 2 2 - - - 2
Sulphuric acid - - — — 1 1 1 -
Table 3. The composition of HPLC mobile phases used during 
attempts to separate degraded salbutamol sulphate 
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Fig. 16. HPLC traces of degraded 0.2% salbutamol sulphate solutions.
Solvent compositions as Table 3. Other conditions as Fig. 14, 
Time scale in minutes.
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being experienced. The compositions are summarised in Table 
3 and the results in Fig. 16. None of the modifications 
significantly improved the separation of the degradation 
products. In most cases the large negative peak due to the 
water in the sample appeared in the middle of the chromatogram 
and could easily have obscured peaks due to breakdown products.
The acidic solvents proved to be totally unsuitable for salbutamol 
as can be seen from Fig. 16.
It seemed apparent that a satisfactory separation would 
not be achieved on silica columns and so Partisil-10 SCX, a 
strong cationic exchanger, was examined. The mobile phase 
consisted of 10% methanol in citrate-phosphate buffer pH 7.4, 
a system which had been used successfully for stability studies 
on phenylephrine in our laboratories (104). The peaks which 
were obtained were very small and poorly resolved and it 
seemed unlikely that improvements could easily be made. 
Consequently, recourse was made to reversed-phase ion-pair 
or "soap chromatography".
The first column tested was 20 cm in length but this 
proved too great because it-resulted in very long retention 
times and short, broad peaks. The pairing ion used was 
dioctyl sodium sulphosuccinate (Mannoxol OT) at a concentration 
of 0.01%. Typical traces, obtained using a high percentage 
of methanol to reduce the retention times, are shown in 
Fig. 17. A smaller pairing ion would be expected to bind less 
strongly to the column and so have a shorter retention time. 
Perchloric acid (O.OIM), which has been used as a pairing ion










20 cm Spherisorb S5 ODS
75% methanol, 0.01% Mannoxol OT,
0.04% sulphuric acid
— iApprox. 1.5 ml min 
UV 254 nm
10 cm Spherisorb S5 ODS
33% methanol, O.OIM perchloric acid
-1Approx. 1.5 ml min 
UV 254 nm
C. As B except Solvent: 37.5% methanol, 0.004%
sodium dodecyl sulphate, 
0.02% sulphuric acid
D. As B except Solvent: 37.5% methanol, 0.004%
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by some workers (81) was therefore studied, as a 50% methanolic 
solution. However, no peaks eluted in less than 20 minutes 
and a similar problem was encountered with sodium dodecyl 
sulphate (0.004%). A small percentage of sulphuric acid 
was used with the latter to ensure that the salbutamol was fully 
ionised and therefore able to form an ion-pair. A 10 cm 
column was prepared in order to reduce the retention times.
The 10 cm Spherisorb 35 ODS column was tested using per­
chloric acid or sodium dodecyl sulphate as the pairing ion 
and the results are shown in Fig. 17. Resolution was better 
using the surfactant as the pairing ion but since Gloor and 
Johnson (81) have reported that a mixture of pairing ions 
can produce improved separations,a ccmbination of perchloric 
acid and sodium dodecyl sulphate was tested. The result 
was a much sharper separation with improved peak heights 
as demonstrated in Fig. 17. Sensitivity could be increased by
changing the detection wavelength to 278 nm (X formax
salbutamol) but the general nature of the chromatogram did 
not change, indicating that degradation products with a markedly 
different absorption spectrum were not being missed.
Having established an adequate separation, an internal 
standard was required to compensate for peak^variations 
due to irregularities in the solvent flow rate or in the 
injection volume. Several compounds (Fig. 18) were tested 
and they are listed, together with their capacity ratios in 
Table 4. Ephedrine proved to be the most promising, being 





















Fig. 18. Compounds tested as potential internal standard s 
for the HPLC assay of salbutamol sulphate.
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Compound Retention time k'Capacity ratio Comments
Salbutamol 3 mins 1.79
AH 6368 6 mins 7 secs 4.22
Phenylephrine 2 mins 37 secs 1.22
Isoprenaline 2 mins 32 secs 1.20
Phenylene
diamine 9 mins 45 secs 5.74
Unstable in 
solution
Ephedrine 4 mins 35 secs 3.19
'Benzyl salbut­
amol ' 10 mins 30 secs 7.46 Very broad peé
Table 4, HPLC data of potential internal standards, 
peak. When added to mildly degraded solutions, it eluted 
between salbutamol and the next degradation peak as indicated 
in Fig. 19. However, in more extensively degraded solutions, 
an additional peak develops in this position and this would 
therefore interfere with the internal standard (Fig. 19). 
Compounds which would elute after all the breakdown products 
had such long retention times that the peak was too broad 
to be analytically useful. It was necessary, therefore, 
either to manage without an internal standard or to separate 
the components of the mixture more efficiently.
The latter option is to be preferred and this led to the 
investigation of SP-Sephadex - C25. This material is a cationic 
exchanger and has been used by the analysts in the industrial 
laboratories to extract salbutamol from syrup formulations 







Fig. 19. HPLC traces of degraded 0.1% salbutamol sulphate
solutions, showing interference of new degradation 
peak with ephedrine, the internal standard. 
Conditions as Fig. 17D.
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with water, through a column of SP-Sephadex gel. This removes 
the sugars and other non-basrio compounds whilst the drug, 
which is basic and ionised, is retained by the ion-exchange 
column. It is then eluted using an alkaline solvent, the 
eluant being collected for assay.
An initial experiment was conducted in which 5 ml of a 
degraded solution of 0 .1% salbutamol sulphate (estimated to 
contain approximately 50% residual drug) was applied to a short 
SP-Sephadex column. The column was washed with water, the 
eluant collected and its uv absorption spectrum determined 
at intervals. Washing was continued until the eluant 
showed no absorption in the range 200 - 400 nm. The eluting 
solvent was then changed to 1% 0.880 ammonia solution and 
the procedure repeated. Samples from both the non-basic 
and basic fractions showing uv absorption between 200 nm and 
400nm were injected onto the HPLC column and the results obtained 
are depicted in Fig. 20.
Fig. 20 clearly shows that the basic fraction contains 
far fewer breakdown products than the original solution, and 
is consequently much better resolved. The small peak which 
caused the problem with the internal standard elutes in the 
non-basic fraction and so is readily removed firom the samples. 
However, the elution from the ion-exchange column necessarily 
dilutes the sample, requiring a higher sensitivity setting 
on the HPLC detector. The sensitivity could also be increased 
by using a wavelength of 278 nm instead of 254 nm but 






Fig. 20.A.HPLC trace of degraded 0.1% salbutamol sulphate solution.
B.HPLC trace of basic fraction of same solution eluted from 
SP-Sephadex column
C.HPLC trace of non-basic fraction of same solution eluted 
from SP-Sephadex.column.
Conditions as Fig. 17D.
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and would therefore be unsuitable as internal standard. However, 
AH 4045 has an absorption spectrum similar to that of 
salbutamol and absorbs strongly at 278 nm. When tested, it
CH
CHCHoNHCMeHO AH 4045
gave a good, sharp peak at the desired position in the chroma­
togram and so was adopted as internal standard.
Baseline resolution between salbutamol and AH 4045 
was just possible using the methanolic solvent system but 
better resolution was found when acetonitrile was used as the 
organic modifier. Typical traces are shown in Fig. 21.
An improvement in the column packing facilities in the 
laboratory enabled a column ’with a higher plate number to 
be used for the subsequent analytical work.
The HPLC system was therefore finally established as:-
Column: 10 cm x 0.4 cm Spherisorb S5 ODS
Mobile phase: 24% acetonitrile
0.004% sodium dodecyl sulphate 
0.06% perchloric acid
—  1Flow rate: Approximately 1.5 ml min
Detection: uv absorption at 278 nm
Internal 
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Fig. 21. A. HPLC trace of G.5% salbutamol sulphate solution. Conditions 
as Fig. 17D.
B. HPLC trace of 0.5% salbutamol sulphate solution. Methanol 
replaced by acetonitrile but other conditions as Fig. 17Dv
C. HPLC traces of progressively degraded salbutamol sulphate 
solutions. Conditions as p. 66.
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2.2 Verification of the HPLC Assay
The HPLC assay procedure efficiently separated salbutamol 
(k'=l.B) and the internal standard, AH 4045 (k'=4.1) in spite 
of the fact that the structural difference between them is 
very small. It therefore seemed unlikely that any degradation 
products would fail to be separated from salbutamol. However, 
in order to verify this, the components of an approximately 
50% degraded solution of salbutamol sulphate were separated 
by preparative TLC, as described in Section 2.7. The bands 
were visualised under uv light, the silica in each was care­
fully scraped off the plate and the adsorbed compounds were 
eluted with methanol. Aliquots of the resultant solution, 
suitably diluted if necessary, were injected onto the HPIC 
column.
All the major degradation products were tested in this 
way and all either eluted well away from the salbutamol peak 
in the chromatogram (Fig. 22) or failed to produce a signi­
ficant peak. It was not possible to correlate the HPLC 
retention time with the Rf value on TLC.
The assay procedure therefore is believed to be stability 
indicating.
2.3 Sample Preparation and HPLC Assay
Short columns of SP-Sephadex C-25 were prepared by soaking 
the dry ion-exchange material in l.OM ammonium chloride 





Fig. 22. HPLC traces of degradation products eluted with methanol 
from preparative TLC plates. Conditions as Fig. 21C.
A. Methanol
B. Degradation product Rf 0.7
C. Degradation product Rf 0.2.
D. Degradation product Rf 0.75-0.8
Dotted lines indicate position of salbutamol.
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and the swollen gel resuspended in distilled water. This was 
repeated three more times before pouring the£slurry into 
the glass columns. The Sephadex gel was supported by a small 
plug of glass wool and sufficient slurry was poured into 
each column to give a depth of approximately 6 cm gel.
The empty column above the Sephadex will subsequently be 
referred to as the column volume. The Sephadex column was 
washed in situ with two column volumes of distilled water 
before use.
Samples fron kinetic experiments were diluted, if 
necessary, to give a nominal concentration of 0.1% salbutamol 
sulphate. 2 ml of this solution (equivalent to 2 mg salbutamol 
sulphate) were applied to the prepared Sephadex column and 
allowed to run into the gel. The column was then washed with 
at least two column volumes of distilled water to remove non- 
basic compounds. In the case of sugar solutions, three column 
volumes were used to ensure complete removal of residual sugar. 
The retained, basic compounds were then eluted with dilute 
ammonia solution which was prepared by diluting 0.880 ammonia 
solution 1 in 100 with distilled water.
A 0.2% stock solution of the internal standard was 
prepared by dissolving 100 mg AH 4045 in 1% sulphuric acid 
to 50 ml, and this solution was then stored in a refrigerator 
for no longer than one month. The eluant from each 
Sephadex column was collected up to the graduation in a 10 ml 
volumetric flask containing 1 ml internal standard solution.
10 yl aliquots of this solution were injected onto the HPLC
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column for assay. The sample preparation procedure is 
summarised in Fig. 2 3.
The mobile phase for the HPLC assay consisted of approx­
imately 24% acetonitrile containing 0.06% perchloric acid 
and 0.004% sodium dodecyl sulphate. This was prepared by 
mixing 240 ml acetonitrile with 760 ml water and degassing 
the mixture under vacuum on a rotary evaporator. To this 
were added 4 ml aqueous 1% sodium dodecyl sulphate solution 
and 10 ml aqueous 6% perchloric acid solution.
“1A flow rate of approximately 1.5 ml min was used and 
a detection wavelength of 278 nm. Typical traces are shown 
in Fig. 21, Peak areas were measured by the Minigrator 
computing integrator and the ratio of the salbutamol peak area 
to that of the internal standard was calculated for each 
injection. At least three replicate injections of each 
sample were made.
The system was calibrated by using a series of solutions 
of salbutamol sulphate, having concentrations in the range 0 .02% 
to 0.15%. Each solution was subjected to the same Sephadex 
pre-treatment as the stability samples and a typical set of 
results is given in Table 5. Three such calibrations were 
performed on different days and the mean data submitted to 
least squares regression analysis (Appendix 1); the results 











Fig. 23. Schematic representation of sample preparation












0.02 0.221 6 0.003 1.36%
0.05 0.518 8 0.004 0.79%
0.08 0.811 7 0.009 1.11% •
0.10 1.006 8 0.004 0.41%
0.15 1.546 8 0.007 0.47%












1 10.153 0.0080 0.156 0.014 0.9996
2 9.105 -0.0059 0.159 0.011 0.9996
3 9.031 0.0028 0.204 0.013 0.9992
Table 6. Details of calibration lines for the HPLC assay of 
salbutamol sulphate
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The slopes of the calibration lines in Table 6 vary by 
about 10% and are therefore significantly different. Because 
of this daily variation in column performance, three standard 
solutions of salbutamol sulphate were always asasyed together 
with the stability samples. These standards (0.1%, 0.05%, 
0.02%) were treated in exactly the same way as the other 
samples and spanned the range of drug concentration in those 
samples. They were interspersed randomly through the day's 
samples for assay and a calibration line was calculated 
from their results using least squares regression analysis 
(Appendix 1). The intercept of this calibration line was 
never of significance and so the concentration of salbutamol 
sulphate in the kinetic samples could be calculated simply 
from the value of the slope. A typieal day's results are 
given in Table 7, together with the method of calculation.
The daily variation in the calibration lines showed random 
scatter as demonstrated by the data in Appendix 2. However, 
the performance of the HPLC column remained stable during 
the course of a working day since replicate injections gave 
the same result when injected at the beginning and end of 
the day (Table 8).
Concentration of 
salbutamol sulphate
Beg. of day's assays Peak area Coeff.of 
ratio variation
End of day's assays 
Peak area Coeff. of 
ratio variation
0.10% 1.019 0.57% 1.017 0.54%
0.02% 0.218 0.38% 0.218 1.85%
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The one anomaly which was noted was in the result obtained 
from the first injection of a new solution. This was nearly 
always markedly different from subsequent results and so the 
first injection was ignored for assay purposes. Examples 
from the assay results for a 0.5% salbutamol sulphate solution 
at pH 7 and 70°, are given in Table 9.






21 hours (0.932),0.892,0.896,0.885, 
0.899,0.898
0.894 0.006 0.64%
45 hours (0.821),0.856,0.853,0.851 0.851 0.006 0.65%
117 hrs (0.677),0.654,0.652,0.652, 
0.651
0.652 0.0013 0.19%
Table 9. Assay results showing anomalous result for first 
injection onto HPLC column. Mean values are 
calculated without the first result.
2.4 Indoaniline Colorimetric Assay
The B.P.C. assay for salbutamol inhalers (73) was modi­
fied for use on the samples from kinetic experiments. The 
samples were diluted with water in order to obtain a nominal 
concentration of 0.1 mg per ml. Into a 50 ml separating 
funnel, 3 ml distilled water and 1 ml of diluted sample were 
pipetted. To this solution the following aqueous reagents 
were added, in order, mixing thoroughly after each addition:
4 ml 5% sodium bicarbonate solution
4 ml 0.1% l-dimethylamino-4-aminobenzene sulphate 
solution
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4 ml 8% potassium ferricyanide solution 
All reagents were freshly prepared
The resultant solution was left to stand for 15 minutes 
away from direct sunlight and then extracted with 2 x 10 ml 
portions of chloroform which were collected in a 25 ml volu­
metric flask and made up to volume. The absorbance of the 
blue chloroform solution was read at 605 nm, according to 
the B.P.C. method.
A series of standard salbutamol sulphate solutions over 
the range 0.10% to 0.02% was used to construct Beer-Lambert 
plots to check the linearity of the response. Each solution 











1 3.008 0.035 0.071 0.0047 0.9992
2 3.138 0.015 0.065 0.0043 0.9994
3 3.046 0.025 0.080 0.0052 0.9990
Table 10. Details of the calibration lines for the colorimetric 
assay of salbutamol sulphate
Both the slopes and intercepts of the Beer-Lambert 
calibrations were subjected to statistical analysis using 
the Bartlett test (Appendix 1). The slopes gave a value
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of 1.722 and the intercepts a value of 8.873. The tabulated 
value at the 5% probability level is 5.991 and so the inter­
cepts differ significantly but the slopes do not. This 
implies that the three calibrations form a family of parallel 
lines (Fig. 24).
It was noted, when using the assay, that the glassware 
became coated with a dark deposit, removable with "chromic 
acid". It is believed that this deposit on the walls of 
the cuvette increased the absorbance reading and produced 
the positive intercept in the Beer-Lambert plots. Small 
variations in the degree of this adsorption would account 
for the differences in the intercepts. In order to eliminate 
this difference when calculating staibility results, the 
value of the intercept was calculated from the absorbance 
of a standard solution assayed with the stability samples.
For this, the value of the slope was taken as 3.064, the mean 
of the three calibrations.
Since the calibration plots are linear, they have the 
general equation:
A = me + b
where A = absorbance, m = slope, c = drug concentration, b = 
constant. For the standard solution. A, c and m are known and 
hence b, the intercept, can be calculated.
The approach was checked by calculating the intercept 
fron each point on one of the calibration plots, using the 























Table 11 and have a coefficient of variation of 13.5%. The 
mean value of 0.0314 is within about 10% of the regression 
line intercept of 0.035.
Salbutamol sulphate 






Table 11. Values of intercepts calculated for each point on 
calibration line No. 1 using value of 3.064 for 
the slope.
2.5 Comparison of Colorimetric and HPLC Assays
Samples frcm several stability experiments were assayed 
by both the indoaniline colorimetric method and the HPLC 
technique (Figs. 25-27, Tables 12-15). In all cases the 
indoaniline method gave appreciably higher results, indicating 
that it estimates some salbutamol degradation products as well 
as the intact drug. This was confirmed by spraying a developed 
TLC of degraded salbutamol solution (approximately 50% residual 
drug) with the indoaniline reagents. The pattern of spots 
visualised was the same as that revealed by the usual MBTH 
reagent (Section 2.6), the only difference being that the 
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Table 12. Comparison of assay techniques for 0.5% salbutamol
sulphate solution, pH 7, 70° containing 0.05% EDTA
Sample Percentage residual salbutamol sulphate




72 69.77 97.06 .
120 57.75 89.88
168 48.58 80.09
Table 13. Comparison of assay methods for 0.5% salbutamol
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Fig. 25. Comparison of assay methods for degradation of 0.5% 
Salbutamol sulphate solution at 70° and pH 7.0 in 


















Fig. 26. Comparison of assay methods for the degradation




Percentage residual salbutamol sulphate






Table 14. Comparison of assay methods for 0 .1% salbutamol
sulphate solution pH 9, 70°, ionic strength 0.5
Sample (pH Percentage residual salbutamol sulphate
adjustment) HPLC Assay Indoaniline assay
Acid 57.36 69.08
Citrate 76.68 89.70
Table 15. Comparison of assay for industrial stability 
samples containing 0.05% salbutamol sulphate, 














Fig. 27. Comparison of assay methods for the degradation 
of 0.1% salbutamol sulphate solution containing 
0.5M NaCl at pH 9.0 and 70°.
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2.6 Thin Layer Chromatography
This was used to monitor the pattern of breakdown under 
various conditions, on a qualitative basis. The plates used 
were commercially pre-coated with a 250 ym layer of silica 
gel G and were impregnated with a uVgg^ fluorescent indicator. 
The developing solvent was that used in the B.P. for Sal­
butamol Sulphate (79) and consisted of ethyl acetate; 
isopropanol: water: ammonia (0.880), in the ratio 50:30:16:4.
Visualisation was by ultra violet light (254 nm), when 
spots were visible as dark areas against a green fluorescent 
background, and by spraying first with MBTH reagent, followed 
by potassium ferricyanide. The spray reagents were prepared 
as follows :
a) MBTH Reagent
loo mg MBTH (3-methyl-2-benzothiazide hydrazone 
hydrochloride iHgO) were dissolved in 10 ml water and 
then made up to 100 ml with methanol
b) Potassium Ferricyanide Reagent
25 ml 0.880 ammonia solution were diluted to 100 ml 
with water. This solution was used to prepare 2% 
potassium ferricyanide solution.
After spraying with both reagents, salbutamol and related 
compounds appear as red spots (Fig. 28). This technique was 
used to monitor the pattern of salbutamol breakdown in nearly 
all the kinetic experiments but was found to be sensitive 
to variations in the laboratoiry temperature, as demonstrated 
in Table 16. A standard salbutamol sulphate solution was
86,
Fig. 28. Photograph of a typical TLC plate, showing the 
spectrum of breakdown as revealed by the MBTH 
reagent spray.
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therefore run as a standard on each plate and Rf values 
(Equation 12) could be used only as approximate guides.







Table 15. Changes in Rf values with temperature for salbutamol 
and its major degradation product, using the 
B.P. TLC system (79)
2.7 Isolation of Breakdown Products
Attempts were made to isolate and identify the major 
degradation products of salbutamol in aqueous solution. A 
combination of the ion-exchange technique developed for the 
preparation of HPLC samples, and thick layer chromatography 
was used.
An SP-Sephadex column, 13 cm long and 1.6 cm in diameter 
was prepared as previously described (Section 2.3). The de­
graded salbutamol sulphate solution was poured onto the 
column and allowed to run through the gel. The Sephadex 
was rinsed thoroughly with several column volumes of 
distilled water to ensure complete removal of the unretained 
non-basic compounds. The basic components of the mixture were
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eluted, as in the analytical procedure, with dilute ammonia 
solution.
During the elution with ammonia, two yellow bands were 
seen to travel down the column. The faster moving band was 
found, by TLC examination, to consist mainly of salbutamol 
but the slower band principally comprised degradation products. 
This band was therefore collected and concentrated on a rotary 
evaporator until approximately 1 ml solution remained. A 
steam bath was used as the source of heat during the evapora­
tion and care was taken to ensure that the flask and its 
contents never became warm to the touch. In this way, further 
degradation should have been minimised.
The concentrated solution was applied as a streak to 
1000 ym thick silica gel G preparative TLC plates, containing 
a '̂̂ 234 fluorescent indicator. ' The plate was allowed to dry 
thoroughly, usually by leaving it overnight, before developing 
it using the TLC solvent system. A continuous elution tank 
was used for the thick layer plates since Rf values tended 
to be lower than on thin layer plates. Development was allowed 
to continue for approximately 34% hours before removing the 
plate and allowing it to dry.
The developed plate was examined under ultraviolet light 
(254 nm) when the bands of the components were visible as 
dark lines against a fluorescent background. The position of 
the band of interest was marked and the appropriate area 
was then carefully scraped off the glass and the silica
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collected in a glass chromatography column. The adsorbed 
compounds were eluted with methanol and this methanolic 
solution was passed through an SP-Sephadex column, washed 
with water and eluted with ammonia as before. This was 
necessary to remove acetamide, formed by the TLC solvent 
and therefore present as a contaminant.
The ammoniacal solution was finally evaporated to dryness 
on a rotary evaporator using a minimum amount of heat. The 
resultant solid was examined by various spectrographic techniques, 
including proton and carbon^13 nuclear magnetic resonance 




Salbutamol sulphate was B.P. grade and was used as supplied by 
Allen and Hanburys Research Ltd. (now Glaxo Group Research), 
without further purification. A single batch was used 
throughout the work.
Buffer salts were of AnalaiR quality.
Sodium hydroxide for the pH-stat was of AnalaR quality.
Glucose and sucrose were AnalaR grade (BDH Chemicals Ltd. ) 
Glycerin and propylene glycol were B.P. grade (Evans Ltd.) 
Fructose was laboratory reagent grade and "glucose free"
(BDH Chemicals Ltd.)
Glyceric acid was obtained as a 65% solution from Aldrich 
Chemicals.
Glyceraldehyde was laboratory reagent grade (BDH Chemicals) 
5-hydroxymethyl furfural was obtained fron Sigma Ltd.
Sorbitol was obtained as a 70% solution from Atlas Chemicals. 
Oxyggn and "high purity" nitrogen were obtained in cylinders 
from Air Products Ltd.
Water was freshly distilled from an all glass still.
Ingold electrode cleaner solutions 9891 and 9892 (Pye Unicam 
Ltd. )
Equipment
Water baths were heated and thermostatically controlled to 
+ owithin - 0.05 by Grant SU6 water bath heaters.
Three sets of pH-stat equipment were used:
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a) Radiometer Titrator 11 
Radiometer Autoburette ABU 12 
Radiometer pH meter 26
b) Radiometer Titrator TTT60 
Radiometer Autoburette ABU 12 
Radiometer pH meter pHM61
c) Radiometer Titrator TTT60 
Radiometer Autoburette ABU 12 
Radiometer pH meter pHM64
Pye Ingold high temperature electrodes (465-90) were used 
as sensors for each unit.
Radiometer glass burettes and pistons of 0.25 ml and 2.5 ml 
capacity were used to deliver the pH-stat titrant.
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2.8 pH-statting
Most published stability studies have been performed 
using buffer salts to control the pH of the system in spite 
of the fact that buffers can affect the rate of reaction 
(10, 42, 44-46). Such an approach therefore necessitates a 
study of the size and nature of such effects so that due 
allowance can be made for them in assessing the results of 
stability experiments.
These problemsare avoided by the use of pH-statting. 
techniques and the interpretation of the results is therefore 
simpler. The effects of buffer salts may then be studied 
separately once the "base-rate" of reaction has been deter­
mined. The pH is controlled by automatic titration equipment 
which monitors the pH and delivers small volumes of a suitable 
titrant to correct any changes.
Three different sets of equipment were used in these 
studies, each consisting of a pH-meter, a high temperature 
electrode, an electronic titration control unit and an 
automatic burette. In each case the manufacturer's speci­
fication of pH control to within - 0.05 pH units was 
determined by the operational limits of the titrator unit 
involved. The TTT60 instruments have now replaced the 
older titrator 11 units in the Radiometer range.
ithough the pH meters have different specifications, 
all were capable of an accuracy of 0.03 pH units or better.
The pH meter 26 which interfaced with the titrator 11 unit
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is now obsolete but the equipment is still functioning per­
fectly. The pHM range of pH meters are necessary to inter­
face with the TTT50 titrators. The specificiation of the 
pHM61, a pointer-scale instrument, is adequate for the 
titrator; the digital pHM64 is a technically superior 
instrument but since the titrator performance is the limiting 
factor, this instrument has no advantage over the pHM61 in 
pH statting units. It was used in this study because of 
its availability within the laboratory.
Pye-Ingold 465-90 high temperature dual electrodes were 
used because they are designed to operate continuously for 
long periods at high temperature. More conventional elect­
rodes, such as the Radiometer GK2401C, although capable of 
sensing pH at temperatures up to about 70°,can only be operated 
for relatively short periods at elevated temperatures.
Prolonged use of the electrodes can result in contami­
nation of the sintered plug linking the glass and reference 
electrode compartments. This causes loss of sensitivity 
and a sluggish response and so sensitivity and response 
rate were checked before and after each experiment, using 
standard buffers (105). The response drift was always less 
than 0.05 pH units. A typical set of results, following 
the degradation of 0.5% salbutamol sulphate in 50% glucose 
solution at pH 3.5 and 70° for 500 hours, gave an electrode 
response of 4.15 for standard phthalate buffer (pH 4.12 at 
70°) and 1.67 for standard tetroxalate buffer (pH 1.68 at 
70°). As a precaution, the electrodes were cleaned at
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intervals with Ingold cleaner solutions 9891 and 9892 according 
to the protocol given by the manufacturer.
The ABU12 autoburettes provide a piston drive to glass 
burettes with capacities of 0.25, 2.5 or 25 ml. These 
instruments can be operated in either continuous or pre­
determined incremental delivery volume modes. The former 
was used in this work, allowing smooth addition of titrant 
on activation by the titrator unit. The speed of titration 
could be varied from 40 seconds to 80 minutes for full burette 
delivery when operated without interruption.
The titrator units are the control modules of the pH- 
statting system. They receive the voltage from the pH meter 
which changes as the pH alters. When the input voltage 
moves outside the range corresponding to the preset pH 
(e.g. pH - 0.05), the titrator activates the autoburette 
which then adds titrant until the voltage, and hence the pH, 
is restored to the predetermined value.
It is therefore important to be able to control the 
rate of titrant delivery so that the pH does not deviate 
significantly from the preset value. If the delivery rate 
is too high, the titrant too strong, the titrator sensitivity 
too low or any combination of these, then the pH correction 
will overshoot as indicated diagrammatically in Fig. 29a.
If the converse situation occurs and insufficient titrant 









Fig. 29. Schematic representation of pH control in pH-stat
(a) Titrant addition too fast or too strong
(b) Titrant addition too slow or too weak
(c) Ideal control.
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so drift away from the required value (Fig. 29b).
A judicious combination of titrator sensitivity, burette 
speed, titrant strength and burette size is therefore nece­
ssary to maintain the pH within the desired limits (Fig. 29c), 
This combination will vary according to the nature of the 
reaction mixture and must be determined by preliminary ex­
perimentation for each set of conditions. The pH variation 
during statting can be monitored on the pH meter and was 
never more than - 0.05 pH units in any experiment.
2.9 General Method
A photograph of the apparatus used is presented in Fig.
30 and the system is represented diagrammatically in Fig. 31.
The pH electrodes were cleaned by soaking in electrode 
cleaner solution No. 9891 followed by solution No. 9892 
for at least three hours each, rinsing well afterwards with 
distilled water. The electrodes were then standardised 
using buffer solutions equilibrated to the temperature of 
the experiment. The buffers used were 0.05M potassium hydrogen 
phthalate and O.OIM sodium borate (105) for experiments at 
pH 4 or higher and 0.05m potassium tetroxalate (105) 
for experiments below pH 4. Buffer solutions were stored in 
a refrigerator for no longer than one month.
The large bulbous reservoir of the high temperature 
electrodes has a high surface area which can cause appreciable
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Fig. 30. Photograph of the pH-stat equipment used for the 
















heat losses. These would result in a temperature gradient 
along the electrode leading to errors in electrode response. 
The portion of each electrode outside the reaction vessel 
was therefore lagged with a 1 cm layer of cellulose wadding 
to minimise heat losses and stabilise the instrument response.
The reaction vessel consisted of a 100 ml or 250 ml 
Quickfit flask with four necks. During an experiment, a 
single coil reflux condenser was fitted to the central neck. 
The other three were used for the pH electrode, the oxygen 
inlet and the pH-stat titrant inlet. Humidified oxygen was 
bubbled through the experimental solutions at a rate of 
10 - 15 ml per minute via a narrow glass tube. There proved 
to be insufficient space within the flask to enable a sintered 
glass oxygen inlet to be used. The oxygen flow provided 
sufficient agitation to ensure thorough mixing of the solution 
without the need for a mechanical stirrer.
The titrant was delivered frcm the autoburette via 
narrow bore polythene tubing (I.D. 2 mm) with a glass tip 
which dipped into the reaction mixture. The glass tip 
was drawn out into a fine capillary which admitted the titrant 
to the reaction vessel in a very thin stream. This was 
rapidly dispersed throughout the solution and so minimised 
the local development of a high pH around the tip. The tip 
was also positioned close to the pH electrode bulb (but not 
touching it) in order to minimise the time lag between 
titrant addition and electrode response and thus minimise
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the chance of "pH overshoot"^ The solution was sampled by 
temporarily removing the oxygen inlet and withdrawing an 
aliquot by pipette.
For kinetic studies on simple salbutamol sulphate solutions, 
75 ml or 175 ml water, as appropriate for the flask size, were 
pipetted into the flask. This was clamped in the water bath 
and allowed to equilibrate for one hour, during which time 
humidified oxygen was bubbled through the liquid. The 
appropriate weight of drug was added as 10 ml concentrated 
solution frcm a 10 ml volumetric flask. This was rinsed with 
measured volumes of distilled water to bring the total volume 
of solution in the reaction vessel to 90 ml or 200 ml.
This procedure was adopted to avoid the need to store concen­
trated stock solutions of the drug which may have proved un­
stable. The temperature change on the addition of the drug 
was negligible, equilibrium being reached within two minutes.
The pH was adjusted to the required value with sodium hydroxide 
solution or sulphuric acid and an initial sample was withdrawn. 
Further samples were withdrawn at suitable intervals, rapidly 
cooled and stored in a refrigerator for no longer than three 
days until required for assay. Samples which were assayed 
immediately and again after seven days gave consistent results 
as demonstrated in Table 17.
In experiments designed to study the effect of other 
compounds on the breakdown of salbutamol sulphate, the 
additive was dissolved in the appropriate volume of water 
and equilibrated in the reaction vessel before the addition
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Sample % salbutamol sulphate remaining (immediate 
assay)
% salbutamol sulphate 
remaining (delayed assay)
pH 5 initial 101.97 (±0.51) 100.89 (±0.79)
pH 9 42 hrs 36.99 (±0.28) 37.24 (±0.36)
50% glucose 
pH 3.5 246hrs
68.53 (±0.35) 68.62 (±0.29)
Table 17. Stability of experimental samples on storage in
a refrigerator for seven days (figures in brackets 
are standard deviations).
of the drug. In all other respects the experiments were 
performed in the same manner as those on simple salbutamol 
sulphate solutions.
The pH-stat titrant was sodium hydroxide solution, 
since the pH always fell as the drug degraded. The strength 
of the titrant was such that the total volume added to the 
flask during an experiment was no more than 1% of the flask 
contents. Concentrations of approximately 1.0 M to 5.0 M 
were usually needed. The settings of the titrator controls 
were chosen to ensure that the pH of the reaction solution 
was maintained within 0.05 pH units of the selected value.
The delayed mixing in the viscous 50% sugar solutions 
necessitated slower titrant addition to prevent overshooting 
the required pH.
2.10 Treatment of Results
The residual concentration of salbutamol sulphate was
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calculated as a percentage of the theoretical initial concen­
tration (Section 2.3, Table 7) and the data plotted against 
time according to first order kinetics. If the graph 
indicated a fairly good linear relationship, the results 
were statistically assessed using least squares regression 
analysis (Appendix 1) to give an apparent first order rate 
constant. When the first order plot was not linear over the 
full course of the reaction, an initial apparent first 
order rate constant was calculated by applying least squares 
regression analysis to the initial, linear, data points 
as illustrated in Fig. 32. When this method has been 
adopted, the number of data points, n, used in the rate con­
stant determination is indicated.
2.11 Reproducibility of Results
The stability of a 2.0% salbutamol sulphate solution at 
pH 9.0 and 70° with an oxygen flow rate of 10 - 15 ml 
per minute, was determined on three separate occasions 
over the course of one month and the data obtained are 
presented in Table 18 and Fig. 33. The first order rate 
constants are also presented in the table and these were 
subjected to a Bartlett test (Appendix 1). The calculated 
value of was 0.866 and the tabulated value at the 5% 
probability level is 5.991. The rate constants are therefore 
not significantly different and the experimental method was 
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Fig. 32. Treatment of non-linear results. The open symbols 
represent points used in the calculation of the 
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Fig. 33. Reproducibility of kinetic results. Degradation
of 2.0% salbutamol sulphate solutions at 70° and pH 9.0.
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2.12 Stability Studies
Most experiments were performed using the general pH- 
statting technique described in Section 2.9. Different 
techniques were adopted for a few experiments and these are 
described at the relevant point.
a) The effect of oxygen
Preliminary experiments carried out with 2% salbutamol 
sulphate solutions at pH 9.0 and 70° showed that when the 
solution was open to the atmosphere via the condenser and 
mechanically stirred with an underwater magnetic stirrer, 
the drug degradation pattern was not reproducible and the 
first order plots were non-linear (Figure 34). Oxygen 
starvation was considered to be the most likely cause of 
these effects. The amount of air drawn into the solution 
by the stirring action would be dependent on the stirrer 
speed and gaseous equilibration is probably slow relative 
to the rate of oxygen utilisation during the degradative 
processes. Consequently, a fine stream of humidified gas 
was bubbled through experimental solutions via a narrow 
glass tube. This not only provided a more efficient gas- 
liquid interface but also ensured thorough mixing of the 
solution (Section 2.9).
The effect of oxygenation was studied by bubbling 
solutions containing 0.5% salbutamol sulphate at pH 9.0 and 
70°, with oxygen at 10 ml per minute and 50 ml per minute 
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Fig. 34. The degradation of 2.0% salbutamol sulphate 
solution in the presence and absence of 
bubbled oxygen.
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data from the three experiments are presented in Table 19 
and Figure 35.
The results indicate that under oxygen the degradation 
rate is almost three times greater than that under nitrogen. 
The graph also suggests that an increase in oxygen flow 
rate from 10 to 50 ml per minute results in no change in 
degradation rate. A "t" test (Appendix 1) between the 
apparent first order rate constants under oxygen gave a 
t value of 1.950 compared with a tabulated value of 2.306 
at the 5% probability level, indicating no significant 
difference between the rate constants. An oxygen flow 
rate of 10 - 15 ml per minute was therefore used in all 
subsequent experiments.
b) The effect of drug concentration
Experiments were conducted at 70° and pH 9.0 using 
salbutamol sulphate concentrations of 0.1%, 0.5%, 1.0%,
2.0%. Linear graphs were obtained when the results were 
plotted according to first order kinetics (Fig. 36) but 
the apparent first order rate constants increased with 
concentration (Table 20), indicating that the breakdown 
of salbutamol sulphate is not a true first order process.
As the degradation rate was shown to be independent 
of ionic strength (Section 2.12c), the half-life of the 
drug at each concentration was calculated from the approp­
riate rate constant (Table 20). The logarithm of the half-life
109.
Oxygen “1(10 ml min ) Oxygen "* 2.(SCtal min ) — 2̂Nitrogen (20mlmin







0 99.54 0 98.89 0 96.70
3 92.51 3 93.23 24 78.60
9 77.78 11 75.01 49 61.71
17 64.06 21 58.65 73 51.21
29 47.35 34 42.90 115.5 35.01
43 33.73 53 27.26
k = 7 —6 —1 .00x10 s k=6 “6 — 1 .81x10 s k =2. ”6 —144x10 s '
Std.Dev. = 7.78 X lo"® Std.Dev.=6.22x10 ^ Std.Dev .=3.47xlo”®
Table 19. The degradation of 0.5% salbutamol sulphate solution at 
pH 9 and 70° under aerobic and anaerobic conditions
100
90 o Nitrogen
-1■ Oxygen 50 ml min80



















Fig. 35. The effect of oxygen on the degradation of 0.5% salbutamol 
sulphate solution at pH 7.0 and 70 .
110.100
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^ 0.5% w/v80











36. The effect of drug concentration on the degradation 
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Salbutamol sulphate concentration (% w/v)
Fig. 37. Half-life plot for determination of order of reaction 
for salbutamol sulphate degradation at pH 9.0 and 70 .
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was plotted against the logarithm of the concentration, 
according to the half-life method for determination of the 
order of reaction (Section 1.3). The result is shown in 
Figure 37, the line of which has a slope of -0.375 with 
a standard deviation of 0.040. The order of reaction is 






























Table 20. Data showing the effect of drug concentration on 
the apparent first order rate constant and half- 
life for the degradation of salbutamol sulphate 
at pH 9 and 70°
c) The effect of ionic strength
The change in the rate constant with concentration could 
be due to ionic strength effects as the ionic strength will 
vary by a factor of 20 over the concentration range 0.1% to 
2.0% salbutamol sulphate. The stability of a 0.1% salbutamol 
sulphate solution in the presence of 0.5M sodium chloride 
at pH 9 and 70° was therefore examined. This concentration -
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of added electrolyte will produce an ionic strength of 
approximately 0.5M which is greatly in excess of that of 
a 2.0% salbutamol sulphate solution (approximately 0.06M). 
The result is presented in Table 21, together with that for 
the solution with no ionic strength adjustment, and is 
depicted in Figure 38.
— 1 6 8Added NaCl k(s )xlO Std.Dev.xlO
None 3.25 3.33
0.5M 3.08 8.33
Table 21. The effect of ionic strength on the apparent 
first order rate constant for the degradation 
of 0.1% salbutamol sulphate solution at pH 9 
and 70°
The rate constants were compared using a Student's t-
test (Appendix 1) which gave a t value of 1.999. The
tabulated value at the 5% probability level and 13 degrees 
of freedom is 2.160 and so the rate constants cannot be 
considered significantly different. Since ionic strength 
had no effect on the rate of degradation, it was not 
adjusted in subsequent experiments.
d) The effect of temperature
The effect of temperature on the rate of breakdown of
salbutamol sulphate was examined at both pH 9.0 and pH 















Fig. 38. The effect of ionic strength on the degradation of
0.1% salbutamol sulphate solution at pH 9.0 and 70 .
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temperatures studied were 50°, 55°, 60°, 70° and 75°, 
whilst at pH 7.0 the range was frcm 60° to 85° in 5° incre­
ments. The temperature was monitored during each experiment 
using a Zeal thermometer calibrated to 0.1° and was found 
to vary by no more than - 0.1°. The apparent first order 
rate constant was determined for each set of conditions 
(Table 22) and the values obtained plotted according to 
the Arrhenius relationship (Fig. 39). These lines were 
subjected to least squares regression analysis (Appendix 1) 
from which the activation energy for the degradative process 












60° 2.03 2.81 0.328 1.06
65° 0.669 1.44
70° 7.00 7.78 1.08 3.92
75° 10.4 12.0 1.48 5.72
80° 3.03 7.22
85° 5.53 9.17
Table 22. The effect of temperature on the apparent first 
order rate constant for the degradation of 0.5% 
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Fig. 39. Arrhenius plots for the degradation of 0.5% 
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The activation energies were subjected to a Student's 
t-test which gave a t value of 0.06. The tabulated value 
at the 5% probability level is 2.365 and so the activation 
energies are not significantly different. This indicates 
that there is no change in the reaction mechanism between 
pH7.0 and pH9.0.
e) The effect of pH
A pH-stability profile of the drug at 70° was generated 
over the pH range 1 - 10, using a salbutamol sulphate conc­
entration of 0.5%. It was found that below pH 4, the 
solutions were self-buffering, rendering the pH-stat un­
necessary. The rate of breakdown was also low in the region 
pH 2 - 5 and so the solutions were kept in stoppered flasks 
and bubbled with oxygen at regular intervals. This allowed 
the pH-stat equipment to be used for other, more rapid 
experiments. The slow degradation rate at low pH values 
meant that some experiments could not be continued beyond 
about 80% residual drug concentration. The extent of 
degradation and duration of the experiment are therefore 
included in Table 24 together with the apparent first order 
rate constants. The whole profile is shown graphically in 
Figure 40.
The drug is evidently most stable in the region pH 3 - 4  
whilst the degradation rate reaches a peak at pH 9. TLC 
examination of solutions degraded at each pH revealed a 
similar pattern of breakdown under all conditions as shown 
in Figure 41.
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""1pH k(s ) Std.Dev. Duration of Final residual
experiment drug concentration
0.85 7.28 X lo"’ 3.14 -8xlO 260 hours 38%
1.5 4.86 X 10-8 2.26 X 10-9 138 days 55%
2.0 3.22 X 10-8 2.94 X 10-9 130 days 80%
3.0 8.08 X 10-9 1.33 X 10-9 294 days 80%
5.0 5.83 X 10-8 4.58 X 10-9 450 hours 90%








X :::: 200 hours 40%
7.5 1.75 X loT* 2.74 X 10-8 140 hours 40%
8.0 3.64 X lO-G 6.61 X 10-8 65 hours 43%








X 65 hours 27%
10.0 5.06 X 10-* 1.80 X 10-7 75 hours 29%
Table 24. The effect of pH on the apparent first order
rate constant for the degradation of 0.5% salbutamol 
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pH 1.5 pH 3.0 pH 5.0 pH 7.0 pH 9.0
Fig. 41. Diagrammatic TLC plate of salbutamol sulphate 
solutions degraded at various pH values.
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f) The effect of buffer salts
Three commonly used buffers were examined at a concen­
tration of O.lM, namely sodium acetate, sodium dihydrogen 
phosphate and citric acid. The solutions were maintained 
at pH 7.0 by pH-statting. A concentration of 0.5% 
salbutamol sulphate was used at a temperature of 70°.
The results are depicted in Figure 42 and the apparent 
first order rate constants are presented in Table 25.







Table 25. The effect of O.lM buffers on the apparent
first order rate constant for the degradation 
of 0.5% salbutamol sulphate solutions at pH 7 
and 70°.
The lines obtained from the experiments using O.lM 
citrate were not linear for either replicate, as can be 
seen from Figure 43. It appears that the degradation slows 
down when the drug concentration falls to about 70% of the 
initial value and then accelerates again below 60% residual 
salbutamol sulphate. The initial and final rates appear 
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Fig. 42. The effect of buffer salts on the degradation 


















Fig. 43. The effect of O.lM citrate on the degradation 
of 0.5% salbutamol sulphate solution at
pH 7.0 and 70 .
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rate constant from the total data (Table 25), the individual 
constants from the first four and last four data points of
one line were also calculated. The values obtained were
-6 + -8 -1 -6 + -8 -11.24 X 10 - 7.86 X  10 s and 1.26 x 10 - 4.83 x 10 s .
These were subjected to a Student's t-test which gave a t-
value of 0.24, the tabulated value at the 5% probability
level being 2.776. The initial and final rate constants are
therefore not significantly different but are about 20% greater
than the overall rate which is reduced by the intermediate
lag phase.
The phosphate results show a similar, but less marked 
discontinuity,the overall effect being an acceleration of the 
rate of salbutamol breakdown, whilst the graph for the 
experiment containing O.lM acetate is linear and shows a 
clear stabilising effect.
g) The effect of EDTA
Oxidation reactions are notoriously sensitive to catalysis 
by trace metal ions, particularly copper, which are often 
present as contaminats, even in high grade materials. These 
ions cire chelated by ethylene diamine tetra-acetic acid (EDTA) 
and are thereby prevented from exerting a catalytic effect.
0.05% EDTA was used with a salbutamol sulphate concentration 
of 0.5% at pH 7.0 and 70°, and the results are summarised 
in Table 26.
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WITH EDTA WITHOUT EDTA
— 1k(s ) Std. Dev. No. of k(s )̂ Std. Dev. No. of
6 8 points. 6 8 points,xlO xlO n XlO xlO n
1.43 11.8 5 0.994 3.50 6
1.51 5.47 7 1.08 3.92 7
Table 26. The effect of 0.05% EDTA on the apparent first 
order rate constant for the degradation of 0.5% 
salbutamol sulphate solutions at pH 7.0 and 70°.
A Student t-test on each pair of results gives a value 
of 1.513 (without EDTA) and 0.652 (with EDTA). These are 
both smaller than the tabulated values of t at the 5% signi­
ficance level and so the data are reproducible under each 
set of conditions, the replicates not being significantly 
different. However, there is obviously a difference between 
the values obtained with EDTA and those without. Surprisingly, 
the EDTA accelerates the breakdown of the drug instead of 
stabilising it as expected. This implies that either a 
stabilising ion is being chelated, or that the EDTA is 
exerting a direct catalytic action of its own.
h) The effect of sugars
The sugars studied were sucrose, which is the principal 
constituent of the oral salbutamol syrup, glucose and fructose
Experiments were carried out using a drug concentration 
of 0.5% at 70° at both pH 7.0 and 3.5. The first experiments 
used a sugar concentration of 10% at pH 7.0 because the
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degradation rate of simple salbutamol solutions is quite 
rapid at this pH. Later work examined the effect of 50% 
sugar at pH 3.5, conditions which approximate to those in 
the commercial syrup.
Figure 44 illustrates the results obtained at pH 7 
using 10% sucrose and 10% glucose. The glucose results give 
a distinctly curved line and so the rate constant in Table 
27 was calculated from the first five data points only. All 
the data were used in the calculation of the apparent 
first order rate constants of the other two lines. The 
graph and table clearly demonstrate that glucose increased 
the rate of salbutamol breakdown by a factor of two but 
sucrose had no effect.
The results obtained at pH 3.5 using 50% sugar are 
depicted in Figure 45. Since the lines deviate from linearity, 
the number of points, n, used in the calculation of the 
apparent first order rate constants is included in Table 28, 
which presents the calculated values. The effect of sugar 
concentration was also examined at pH 3.5 using sucrose.
The rate constants are included in Table 28 and the results 
are shown graphically in Figure 46.
The most striking difference between the results at 
pH 7.0 and 3.5 is in the effect of sucrose. Although this 
sugar had no effect on the rate of salbutamol breakdown at 
the higher pH, at 3.5 the rate was increased substantially.
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Fig. 44, Degradation of 0,5% salbutamol sulphate solution at 
pH 7 and 70° in the presence of 10% sugar







Table 27. Apparent first order rate constants for the degradation 
of 0.5% salbutamol sulphate solutions at pH 7.0 and 
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Fig. 45. Degradation of 0.5% salbutamol sulphate solution at pH 3.5 
and 70° in the presence of 50% sugar
Sugar concentration 
% w/v
pH control -1 7 k(s )xl0 Std.Dev. n
50% glucose pH stat 3.97 2.00 6
50% glucose citrate 4.14 1.01 3
50% fructose pH stat 4.22 4.19 5
50% sucrose pH stat 4.81 1.75 6
50% sucrose citrate 4.33 1.93 3
10% sucrose pH stat 0.544 0.308 6
Table 28. Apparent first order rate constants for the degradation
of 0.5% salbutamol sulphate solutions at pH 3.5 and
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Fig. 46. The effect of sucrose concentration on the
degradation of 0.5% salbutamol sulphate solution 
at pH 3.5 and 70°,
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the degradation to approximately the same extent as sucrose, 
resulting in a half-life for the drug of about 400 hours.
In the absence of sugar no detectable breakdown occurs over 
a similar time period, as illustrated in Figure 45. Figure 
46 shows that the accelerating effect of sucrose at this 
pH is concentration dependent and the rate constant data in 
Table 28 reveal a eight-fold increase in the rate constant 
for a five-fold increase in sucrose concentration.
The HPLC traces of the degraded samples containing. 
glucose and fructose showed the presence of an additional 
peak (k* = 0.40) which eluted before salbutamol (Fig. 47).
A similar peak was observed in pH 3.5 samples containing 
sucrose but not in sucrose samples at pH 7.0. Since no 
acceleration of the degradation rate was observed in the 
presence of sucrose at pH 7.0, the new peak must represent 
a new decomposition product, the formation of which increases 
the rate of loss of salbutamol sulphate, and is probably 
the result of a reaction between the drug and excipient.
i) The effect of citrate buffer in the presence of sugars
The commercial syrup contains a citrate buffer to 
control the pH and so, although citrate had been shown to 
have little effect at pH 7 (Section 2.12f), its effect at 
pH 3.5 in the presence of 50% glucose and 50% sucrose was 
examined. The buffer was the same as that used in the for­
mulated product and consisted of 1.0% citric acid and 0.575% 
sodium citrate. The apparent first order rate constants 
calculated from the results , which are plotted in Figure 48,
131 .
Time in minutes
Fig. 47. HPLC traces of degrade 0.5% salbutamol sulphate solutions 
containing 50% polyhydric excipients at pH 3.5 and 70°. 
Conditions as Fig. 21C.
A. Glucose (200 hours)
B. Sorbitol (350 hours)
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Fig. 48. The effect of citrate buffer on the degradation of 0.5% 
salbutamol sulphate in the presence of 50% sugar at 
pH 3.5 and 7o^ (a) sucrose (b) glucose
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are also included in Table 28. As before, the number of points 
used in the computation of each line is tabulated. A Bartlett 
test (Appendix 1) on the data for 50% sugar at pH 3.5 gave 
a value of 6.31. The tabulated value at the 5% probability 
level for 4 degrees of freedom is 9.488 and so the initial 
rate constants do not differ significantly. However, it is 
apparent from the graphs (Figs. 45 and 48) that differences 
between the sugars do exist and that citrate has a small 
stabilising effect which only becomes apparent when the 
residual drug concentration has fallen to about 70%.
j) The effect of polyhydric excipients
In order to determine the nature of the reaction between 
sugars and salbutamol, several types of compound with diff­
erent functional groups were studied. One group of compounds 
consisted of propylene glycol, glycerol and sorbitol. These 
all have a single type of functional group, the alcoholic 













Initially, propylene glycol and glycerol were used at 
a concentration of 10% with a drugeconcentration of 0.5% at 
pH 7.0 and 70°. Figure 49 illustrates the results obtained. 
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Fig. 49. The effect of polyhydric alcohols on the
degradation of 0.5% salbutamol sulphate at
pH 7.0 and 70 .
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-6 -1was estimated to have a rate constant of 2.4 x 10 s 
This then falls to a value of 1.03 x 10 ^ s  ̂- 1.66 x 10
The more linear glycerol graph gave a rate constant of
“6 ” 1 4" —Q1.33 X 10 s - 7.83 X 10 , an increase of approximately
30% over that for a simple solution of pH 7.
Glycerol and sorbitol were then examined at the 50% 
level at pH 3.5, as a comparison with the sugar effects 
under these conditions. The results are depicted in Figure 
50 frcHn which the initial apparent first order rate constants 
were calculated. Like the sugars, these polyhydric alcohols 
accelerated the breakdown of salbutamol sulphate and an 
additional peak appeared in the analytical chromatogram.
The peak from the sorbitol samples had a k'value of 
approximately 1.0 whilst the glycerol product could only just 
be separated from salbutamol, having k ' = 1.75 (Figure 47).





Glycerol 4.03 2.24 4
Sorbitol 5.25 2.63 5
Table 29. The apparent first order rate constants for
the degradation of 0.5% salbutamol sulphate 
solution at pH 3.5 and 70° in the presence of 
50% polyhydric alcohols.
A Bartlett test was used to compare the sorbitol rate 
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Fig. 50 . The effect of polyhydric alcohols on the degradation
of 0.5% salbutamol sulphate at pH 3.5 and 70 .
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sugars. The value obtained was 18.09 which is greater
than the tabulated value of 11.07. This confirms that the
degradation rate in the presence of 50% sorbitol at pH 3.5 
is significantly greater than in the presence of sugars under 
similar conditions.
k) The effects of 9lyceraldehyde and glyceric acid
The most reactive centre in a sugar molecule is the
anomeric carbonyl carbon atom (Section 1.6) and so this 
is a likely point of interaction with salbutamol. The 
carbonyl group is also sensitive to oxidation, being con­
verted to a carboxylic acid. If this were to occur under 
the experimental conditions used in this study, the reactive 
species could be the aldonic acid instead of the aldose.
Although not usually classified as a sugar, glyceraldehyde 
bears the same relationship to glucose as glycerol does to 
sorbitol and so may be considered to be the simplest aldose.
It differs from most sugars in not being able to form a 
cyclic structure due to the brevity of the carbon chain. 
Oxidation of the carbonyl group produces glyceric acid and 
so the stability of salbutamol sulphate in the presence of 
these two compounds was examined, in an attempt to determine 
the nature of the active functional group in salbutamol - 
sugar reactions.




Solutions containing 0.5% salbutamol sulphate and 5% of 
the test compound were used. The low solubility of glyceral- 
dehyde precluded the use of concentrations as high as 10%, 
as had been used for glycerol and the sugars. The pH was 
3.5 and the temperature 70°, as before.
Figure 51 demonstrates the unexpected nature of the 
results. Glyceraldehyde, whilst slow to produce an effect 
at first, rapidly accelerated the breakdown of the drug 
whereas glyceric acid, after a similar time interval of 
about 50 hours, produced a plateau with about 73% residual 
salbutamol sulphate.
1) The effect of 5-hydroxymethylfurfural (5-HMF)
5-HMF is a major product of the breakdown of sugars and 
is believed to be an intermediate in many sugar reactions 
(58, 59, 106-108). Three concentrations were tested, 0.015%, 
0.03%, and 0.10%, all at pH 7 and 70° with a salbutamol 
sulphate concentration of 0.5%. The concentrations were 
chosen to cover the likely range of 5-HMF production from 
10% glucose at pH 7 (58, 107, 108). Formation of 5-HMF at 
pH 3.5 will be minimal since this is the region of maximum 
glucose stability (56-58).
The results indicate (Fig. 52) that 5-HMF does not 
have a marked effect on the degradation of salbutamol sulphate 
but at low levels may have a stabiJ oing effect. The graph 
for 0.015% 5-HMF is distinctly curved and so an apparent 















Fig. 51. The effect of glyceraldehyde and glyceric acid 
on the degradation of 0.5% salbutamol sulphate 













Fig. 52. The effect of 5-hydroxymethylfurfural (5-HMF) on the 
degradation of 0.5% salbutamol sulphate solution at
pH 7.0 and 70 .
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data points only. All the points were used for the other 












Table 30. The effect of 5-HMF on the apparent first order 
rate constant for the degradation of 0.5% 
salbutamol sulphate at pH 7 and 70°.
The three rate constants were compared with each other 
using Bartlett's test (Appendix 1) which gave a value of 1.416 
for The tabulated value at the 5% probability level
is 5.991 and so the three constants do not differ significantly. 
The data were also compared with that obtained for 0.5% 
salbutamol sulphate solutions at pH7 and 70° in the absence 
of 5-HMF. The calculated value in this test was 5.475 and 
the corresponding tabulated value is 9.488. The data there­
fore do not show statistically significant variation at the 
5% probability level.
142.
Section 3. IDENTIFICATION OF BREAKDOWN PRODUCTS
3.1 Introduction
Attempts were made to isolate and identify the major 
degradation products of salbutamol sulphate in aqueous 
solution, using the method described in Section 2.7.
However, in simple solutions, from the large number-of 
compounds formed (Fig. 4.1), only one could be isolated 
in sufficient quantity for further study. This formed the 
largest spot on TLC, apart from salbutamol itself, and had 
an Rf value of 0.75 - 0.80.
The compound was isolated as a pale yellow or 
colourless solid. Its solution (methanolic or aqueous) 
darkened on standing, -turning deep yellow and then brown.
It was examined by both and ^^C-nmr and also subjected 
to mass spectrometry, in order to determine its structure.
Products which were formed, as a result of the inter­
action between salbutamol sulphate and sugars underwent 
breakdown during attempted purification. The only compound 
which was isolated exhibited the characteristics of sal­
butamol and not the original interaction product when 
examined by ^H-nmr and TLC. However, the product from 
the interaction of salbutamol sulphate and glycerol was 
considerably more stable and was isolated and examined 
by ^H- and ^^C-nmr.
The nmr spectra of salbutamol were determined initially
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for reference purposes. The ^H-nmr spectrum of salbutamol 
is depicted in Fig. 53. The large peak at 61.2 is due 
to the nine t-butyl protons and was used as the basis 
for determination of the peak area ratios. The data 
are presented in Table 31, together with the peak 
assignments.
6(ppm) Peak Splitting Coupling constant 
J (Hz)
Assignment
1.2 singlet - -0 (082)3(9)
2.8 doublet 6.0 -CH^N- (f)
4.45 singlet - -CH^OH (e)
4.8 triplet 6.0 -CH (OH) - (d)
6..75 doublet 7.8 Aromatic(c)
7.05 double doublet 7.0,3.0 Arcsnatic (b)
7.3 doublet 2.0 Aromatic(a)
CH.OH
CHCH2NHC(cH3)
Table 31. H-nmr data for salbutamol in DMSO-d^ with6
TMS internal standard.
Noise decoupled and the off-resonance ^^C-nmr spectra 
gave signals which were unequivocally assigned (Table 32), 
the assignments being in accord with the data published 













Chemical shift C-HCoupling Assignment
153.3 singlet Aromatic (d)
134.4 singlet Aromatic (a)




114.1 doublet Aromatic (c)
72.3 doublet -CH(OH)-
58.6 triplet -CHgOH
50.5 triplet -c h n̂ h-
49.5 singlet -NHC(Me) ,3
28.7 quadruplet -CfCH])]
H
13Table 32. C-nmr data for salbutamol in DMSO-d^ with
TMS as internal standard
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3.2 The major degradation product in simple solution
The ^H-nmr spectrum of the principal degradation 
product of salbutamol sulphate in aqueous solution is 
depicted in Fig. 54. The main difference between this 
spectrum and that of salbutamol (Fig. 53) is the 
additional peak at 63.8. The integration suggests the 
presence of 5-6 aromatic protons, that is, two tri­
substituted aromatic nuclei, but only one t-butyl group. 
The data from the ^^C-nmr spectrum of the compound is 
presented in Table 33 together with the comparable data 
for salbutamol itself. The similarity between the 
salbutamol and degradation product signals suggests 
that most of the molecule has undergone little change.
The small quantity of, possibly impure, material 
which was available precluded a detailed study but some 
conclusions as to the nature of the conpound can be drawn. 
The increase in the number of aromatic protons and 
carbon atoms with retention of a single t-butyl group 
suggests an alkylation by one salbutamol molecule with 
complete loss of one side chain. The mechanistic inter­
pretation of the loss of the side chain is problematical 
although hydramine fission would remove the amino group.
Ar-C-CHgNHg------------> ArCOCH^ + NH^
Hydr amine 
fission


































Table 33. ^^C-nmr data for salbutamol and its principal 
degradation product. Spectra run in DMSO-d^ 
with TMS as internal standard.
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H,OH
Fig. 55. Possible structure of major degradation product 
of salbutamol sulphate in simple aqueous 
solution.
The signal at 63.8 in the proton spectrum (Fig. 54) 
and at 642.0 in the spectrum (Table 33) would be due 
to the methylene bridge between the two aromatic rings. 
This is in accordance with data for di-(4-methoxyphenyl) 
methane which has a value of 640.0 for the carbon 
resonance (139). Application of Shoolery ' s rule (Equation 
13) gives a value of 3.98 for the proton resonance at 
this carbon atom(138).
= 0.28 + la (13)erf
where 6 = chemical shift of substituted methylene group
and a is Shoolery's constant for substituents, eff
The slight shifts in the positions of the remaining 
peaks in the spectrum compared to those in salbutamol 
are probably attributable to the change in the solvent 
used. This change was necessary to enable the compound 
to be recovered later, methanol being volatile whilst 
DMSO is not.
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The mass spectrum of the compound was too complex for 
immediate interpretation and it is likely that the ccmpound 
was insufficiently pure for this technique to provide 
useful information. There was no significant peak at m/'e 
345, the molecular ion (M̂ ) of the proposed structure, but 
a signal was present at m/e 327 which may represent M-HgO. 
Other fragmentation peaks could not be assigned with any 
degree of certainty.
3.3 The glycerol-salbutamol reaction product
The ^H-nmr spectrum of the product of the reaction 
between glycerol and salbutamol sulphate is shown in 
Fig. 56, where it can be seen that the most striking 
difference is in the region Ô3.2-4.0. The integration 
of this group of peaks suggests an increase in the number 
of aliphatic protons. This fits the concept of a simple 
addition of glycerol, since the remaining peaks closely 
resemble those of salbutamol (Fig. 53).
Lack of compound prevented a well resolved 
spectrum being obtained, but the available data is presented 
in Table 34. There appears to be an increase in the number 
of aromatic carbon atoms together with an increase in 
signals around 62 - 81 ppm. Signals from the glycerol 
framework would be expected to appear in this region but 
there appear to be more than were indicated by the proton 
spectrum, perhaps due to in̂  raction between glycerol 

















134.2, 130.8, 129.2 











13Table 34. C-nmr data for the product of the reaction 
between glycerol and salbutamol. Spectrum 
run in d^-methanol with TMS internal 
standard.
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The compound is very similar to salbutamol in 
polarity, its HPLC capacity ratio being 1.75 compared 
to 1.8 for salbutamol. However, thid does not offer 
much assistance in assigning a structure to the compound.
The most likely point of attack would appear to be 
the nitrogen atom in salbutamol, leading to'formation 
of a glycosidic compound or a Schiff base. This, in 










Fig. 57. Possible structure and further degradation of 
the glycerol-salbutamol reaction product.
The main problem with such a scheme, apart from the 
fact that neither structure accounts satisfactorily for 
all the signals in the nmr spectra, is that the ring 
clsoure has to take place meta to the phenolic hydroxyl. 
This is not an activated position, such closures generally 
occurring ortho or para to the phenolic group.
A further complication arises frcm the instability 
of the compound. Its solution darkened considerably on 
standing and whilst the ^H-spectrum could be run within
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a few .minutes, the spectrum required a long accumulation 
time and so could have been significantly affected by 
degradation of the compound. As a result, it is 
impossible to unequivocally assign a structure to the 




Pharmaceutical stability studies may be approached 
qualitatively or quantitative,ly, the method chosen being 
largely dependent on the analytical techniques available. 
Qualitative studies involve the monitoring and identifi­
cation of breakdown products but actual measurement of 
the extent of degradation is limited, often employing 
techniques such as TLC-densitometry. In contrast, when 
a reliable, specific assay for the compound in question 
is available, a quantitative approach may be adopted. 
Although breakdown products still need to be identified 
to confirm that toxic compounds will not accumulate in the 
formulation on storage, the principal method of assessing 
stability samples in this case is by assay of the active 
components.
In this study, a stability indicating assay was 
developed with the aim of taking the second approach. 
Attempts were made to isolate and identify the major 
breakdown products in order to determine the degradative 
pathway of the drug. Unfortunately these compounds proved 
to be rather labile and appreciable breakdown occurred 
during the isolation processes so that definitive identi­
fication of any one compound was not possible (Section 3).
The validity of using the HPLC technique for stability 
studies was tested initially by injecting closely related 
compounds such as AH6368 and isoprenaline and measuring 
their capacity ratios (k'). All the compounds tested
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(Table 4) were separated from salbutamol, even though in 
some cases the structural differences were small (Fig. 18). 
The internal standard, AH4045, which differs only in one 
ring substituent was fully resolved from the drug (Fig.
21). This suggested that breakdown products would also 
be well separated from the intact drug but in order to 
confirm this, the major degradation products were separated 
by preparative TLC (Section 2.2). Since these confounds 
were rather labile (Section 3), they were not isolated 
in a dry state but maintained in solution and injected 
onto the HPLC column immediately after elution from the 
TLC silica. All those which gave a significant peak in 
the HPLC chromatogram at the usual analytical sensitivity, 
eluted well away from salbutamol (Fig. 22). It was 
possible, by increasing the detector sensitivity by a 
factor Of 4, to detect small peaks in some of the other 
samples and in a few cases, these coincided with the 
position of salbutamol in the chromatogram. However, 
since the salbutamol peak would be completely off-scale 
at such a sensitivity, these compounds did not present a 
problem in the assay of the drug by this technique.
The method was therefore accepted as stability indicating 
and was used to assay the samples from stability 
experiments.
It appeared that the more polar compounds eluted 
fastest from the HPLC column, AH4045 and "benzyl-salbutamol" 
having longer retention times than salbutamol itself. 
However, it was not possible to directly correlate Rf
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values from TLC with k ' values frcm HPLC, as demonstrated
in Table 35.




Major degradation product 0.75 4.8
S albut amol-glucose 
adduct 0.85 0.40
AH4045 0.9 4.1
Table 35. TLC and HPLC parameters of salbutamol and 
related compounds.
This lack of correlation is not really surprising as the 
separation mechanisms operating in the two systems are 
completely different. If it had proved possible to develop 
a satisfactory separation on a silica HPLC column, corre­
lation between TLC and HPLC may have been possible as 
claimed by some workers (101, 102). However, the differences 
in the chromatographic conditions make such generalisations 
unreliable. Equilibrium is seldom achieved in TLC and 
so the solvent composition alters as it progresses up 
the plate, resulting in variation in separation efficiency.
A well conditioned HPLC column, however, should be uniform 
in its efficiency throughout its length. TLC is also 
much more sensitive to temperature fluctuations. The 
running speed and hence the separation of salbutamol
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solutions changed considerably with the ambient temperature 
as demonstrated in Table 16. The HPLC separation was 
not sensitive to temperature and although temperature 
control with a water-jacketed column was tested, it did 
not affect the separation or capacity values of the solutes.
The principal difference between the two chromato­
graphic systems lay in the number of degradation products 
detected. Most HPLC traces showed the presence of only one 
or two breakdown products whilst TLC detected six or more 
in extensively degraded solutions.. This demonstrates 
a potential pitfall in the interpretation of analytical 
results. Taken alone, the HPLC results would suggest a 
simple degradation pathway leading to the production of one 
or two new compounds. Elucidation of the breakdown mechanism 
of salbutamol sulphate might therefore be expected to be 
relatively straightforward. By contrast, the TLC plates 
of degraded salbutamol solutions reveal such a complex 
pattern of compounds that development of a specific assay 
for the intact drug might be deemed almost impossible.
In addition, degradation might qualitatively appear to 
be more extensive them it really is since many of the 
detected compounds are present in only very low concen­
trations. Both techniques are obviously of great value 
but the significance of the data they produce must be 
assessed with care.
The reason for the difference between the chromatograms 
obtained from the two techniques, as used in this study.
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is two-fold. The preliminary separation by ion-exchange 
chromatography removes several compounds prior to injection 
onto the HPLC column, as demonstrated by the HPLC traces 
in Figure 20. The other factor relates to the high 
sensitivity of the colorimetric spray reagent used to 
visualise developed thin layer chromatograms. This is 
able to detect compounds at extremely low concentrations 
as was shown during the verification of the HPLC assay. 
Although several breakdown products were detected by the 
spray reagent and eluted from preparative TLC plates, 
some did not produce recognisable peaks in the HPLC 
chromatogram unless the sensitivity of the detector was 
increased by a factor of 4 to its maximum. Even at this 
sensitivity, the resultant peaks were very small and 
almost lost in the background "noise". It is possible 
that seme of these compounds had different absorption 
spectra from salbutamol and could have been detected at 
a different wavelength. In order to check this, an 
approximately 50% degraded solution of salbutamol sulphate 
was prepared for assay in the usual way (Section 2.3) and 
injected onto the HPLC column. The detection wavelength 
was increased by 5 nm between injections and in this 
way the solution was scanned between 240 nm and 290 nm. 
There was no noticeable change in the number of peaks in 
the chromatogram, or in their relative intensity, and so 
it is unlikely that the HPLC assay "missed" compounds due 
to their having different absorption spectra.
The value of having two separation techniques was
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demonstrated very clearly when salbutamol degradation in 
the presence of sugars was studied. The monosaccharides 
glucose and fructose formed a compound with salbutamol 
which ran on TLC with an Rf value, at 20°, of about 
0.85. On HPLC the compound had a short retention time, 
appearing soon after the solvent peak and before salbutamol, 
suggesting that it was considerably more polar than sal­
butamol. Similar experiments with the polyhydrics sorbitol, 
glycerol and propylene glycol revealed an interesting 
trend. Sorbitol produced a compound which behaved very 
similarly to that produced by glucose and fructose, whilst 
propylene glycol formed an adduct which eluted on HPLC 
between salbutamol and AH4045 . Initial experiments with 
glycerol suggested that no reaction had occurred because 
no additional peak appeared in the chromatogram. This 
seemed unlikely in view of the close structural relationship 
of the three excipients. Since sorbitol, with six 
hydroxyl groups gave a compound with a capacity value of 
1.0 and propylene glycol, with only two hydroxyls resulted 
in a compound with the larger value of 2.75, by inter­
polation, the three hydroxyls of glycerol should result 
in an intermediate capacity value which could coincide 
with that of salbutamol (k' = 1.8) . TLC examination of 
the solution confirmed the presence of an additional 
compound, well separated frcm salbutamol (Rf 0.60) at an 
Rf of about 0.42 (Fig. 58). The use of a more efficient 
column having 1350 plates instead of the original 500 
enabled the two compounds to be resolved sufficiently 



















Fig. 58. Diagrammatic TLC plate of a standard 0.5% salbutamol
sulphate solution, together with a sample degraded
for approximately 500 hours at pH 3.5 and 70° in
the presence of 50% glycerol.
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The preliminary work using simple degraded solutions 
of salbutamol sulphate was therefore unable to predict 
the analytical problems which would arise on the addition 
of other substances. It is therefore essential to reassess 
all analytical techniques regularly in the light of 
additional information.
A good example of the need to update assay procedures 
to incorporate new developments is provided by the con­
trasting results obtained by the indoaniline and HPLC 
methods. The colorimetric reaction evidently assays a 
considerable proportion of the degradation products as 
salbutamol, since the results from this method were 
significantly higher than those obtained by the chromato­
graphic technique (Tables 12 - 15, Figs. 25 - 27) and 
the same spectrum of breakdown was visualised on TLC 
plates by both the indoaniline and MBTH spray reagents.
The reason for this overestimation by the indoaniline 
reaction lies in the fact that modifications to the amino 
side-chain of salbutamol would result in the same indo- 
aniline dye since this portion of the molecule is "lost" 
during the reaction (Fig. 11). An additional problem arises 
from the fact that although a chemically different dye will 
result frcm a change in the ring substitution of the drug, 
the absorption spectrum of this dye is likely to overlap 
that of the dye formed fron salbutamol. Overestimation of 
the salbutamol content of degraded solutions is therefore 
inevitable.
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It is interesting to note that the difference in assay 
results between the two techniques varies with the degra­
dative conditions. This is summarised in Table 36 which 
gives the colorimetric results equivalent to an HPLC assay 
of 57% under various conditions. This data is taken from
Conditions HPLC Colorimetric
0.1% pH 9.0 57% 70%
0.5% pH 7.0 57% 89%
0.05% pH 3.5 57% 69%
Table 36. Comparison of assay methods for salbutamol 
sulphate.
Table 15 and Figs. 25 and 26. It is apparent that the 
discrepancy between the two methods is greatest at the 
highest concentration but it is likely that the pH 
differences also have an effect. The differences between 
the two sets of results suggest a change in the degradation 
products under varying conditions although TLC examination 
did not detect significant changes in the breakdown pattern 
with pH (Fig. 41) or concentration. However, since it is 
difficult to estimate the intensity of TLC spots visually, 
it is possible that there were scxne changes in the relative 
proportionsof some degradation products which were not 
observed.
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A further consideration is that the colorimetric 
method is laborious and time-consuming whilst the HPLC 
method, in spite of the preliminary sample preparation is 
cleaner and quicker, allowing replicates to be performed 
more easily. It would probably be possible to modify 
the system to incorporate an ion-exchange pre-column, 
enabling sample preparation and assay to be carried out 
in one operation. A greater through-put of samples could 
also be achieved with an autoinjector.
The reproducibility of the HPLC assay proved satis­
factory within any one day, replicate injections usually 
having a coefficient of variation of less than 1.0%.
The only exception to this was the first injection of a 
new solution which often gave an anomalous result. The 
peak area ratio of this injection was often high if the 
previous solution had been more concentrated or low if 
more dilute (Table 9).and this sug^sted inefficient 
rinsing of the syringe between samples. In order to 
correct this, the syringe and loop were rinsed four times 
with distilled water and four times with the new solution 
before making an injection but this did not improve the 
result. As a consequence, the result for the first 
injection of a new solution was always ignored. The 
reason for this anomaly is not clear but would appear to 
be a function of the column itself. It is possible that 
a certain percentage of any injection is retained by the 
column, a new injection displacing the retained portion
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of the previous one. The percentage must be the same for 
each solution since the calibration lines were linear and 
passed through the origin.
Table 5 shows that the reproducibility of a single 
determination tended to improve with increasing concen­
tration. The most dilute solution (0.02% salbutamol 
sulphate) gave results with a coefficient of variation, 
over six determinations, of 1.36%. The more concentrated 
solutions usually showed a variation of less than 1.0% and 
often less than 0.5%. This is a very acceptable level of 
reproducibility for this type of assay procedure. The 
increase in variability with falling concentration tends 
to provide the lower limit for the assay. In this study, 
0.02% solutions were the most dilute to be used routinely. 
This refers to the concentration before Sephadex treatment 
which diluted the samples by a factor of 5. The assay 
therefore detected 0.04 mg salbutamol sulphate per ml 
(0.4 yg in 10 yl sample) as used routinely. More dilute 
samples could be processed by increasing the detector 
sensitivity enabling 0.1 yg to be detected, or by in­
creasing the volume applied to the Sephadex column.
The columns could handle at least 2 mg salbutamol sulphate 
and so this could be applied in as large a volume as 
necessary and still be eluted into 10 ml. This would enable 
the system to be used on the same settings for a wide 
range of sample concentrations.
The daily variation in the column performance (Table 6)
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necessitated daily calibrations. Three standard solutions 
were used to ensure that the calibration was linear and 
these were interspersed throughout the day's samples. No 
drift in the calibration was found over the course of a 
day, since standards injected at the beginning and end of 
the day gave the same result (Table 8). Similarly, 
standards were not assayed in any particular order yet 
always gave a line which had a standard deviation to slope 
ratio of less than 3%. The variation in the slope of the 
calibration line was random over the course of a year 
(Appendix 2) and no pattern could be detected. The mean 
value of the slope obtained from the data in Appendix 2, 
is 9.495 with a coefficient of variation of 6.1%. This is 
in close agreement with the mean of the values in Table 6 
which is 9.43 with a coefficient of variation of 6.6%, even 
though the latter data arises frcm 5 point calibrations 
instead of 3 point. This serves to confirm that the varia­
tion is truly random with no apparent long term trend.
The effect was not temperature dependent because use of 
a water-jacket to control the column temperature did not 
improve the reproducibility. The drift must be related 
to the conditions in the column when no solvent is flowing 
through it, since changes only took place when left, for 
example, overnight and not when used over a similar 
period. The packing material may settle or expand, due to 
relaxation, during this time or accumulated contamination 
may elute whilst conditioning the column for a day's 
analysis. The randomness of the phenomenon seems to rule 
out progressive breakdown of the column.
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4.2 Authenticity of kinetic data
The overall reproducibility of the kinetic experiments 
was dependent largely on the reliability of the assay and 
the stability and accuracy of the pH stat equipment.
Although most pH electrodes can be used at temperatures 
up to about 70°, they are stable at elevated temperatures 
for only a few minutes and so are unsuitable for long term 
pH monitoring as required by the pH-statting technique 
used in these studies. Most experiments lasted for several 
weeks and so pH drift had to be minimal. Special high 
temperature electrodes were therefore used which have a 
large bulbous reservoir of electrolyte. The lagge 
surface area of this reservoir makes it a potential source 
of considerable heat loss which could result in a temperature 
gradient along the length of the electrode. This, in 
turn, could produce erroneous fluctuating readings and so 
the electrode bulb and stem were lagged to minimise heat 
losses. In fact, identical pH readings were obtained 
with unlagged electrodes but lagging was used to reduce 
the possibility of pH drift due to draughts during the 
course of an experiment.
A further complication arose from the nature of 
degraded salbutamol sulphate solutions. As breakdown 
of the drug proceeded, the electrodes often became 
coated with a brownish deposit which could potentially 
affect their response. However, when checked with 
standard buffers at the end of an experiment, they were 
found to be accurate to within - 0.05 pH units (see
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p.93 ). Addition of titrant was therefore initiated 
by real pH changes ensuing from degradation of the drug 
and not instrumental drift.
The reproducibility of the kinetic experiments was
established at the outset of the work using 2.0% salbutamol
sulphate solutions at pH 9.0 and 70° (Table 18). The
mean value of the apparent first order rate constant
— ̂ ** 1from these three experiments was 9.94 x 10 s with 
a coefficient of variation of 1.4%. This represents 
good reproducibility and so the experimental method was 
believed to be reliable. Under the conditions used 
for this initial study, results could be obtained quickly 
but most of the subsequent work used more dilute solutions 
and milder conditions and so experiments often took 
several weeks to complete. In the extreme case, one 
experiment at pH 3.0 and 70° lasted nearly 10 months 
and still achieved only 20% degradation. It was therefore 
impractical to repeat every experiment if the time and 
equipment were to be used to the best advantage.
A further difficulty lay in the shape of the graphs 
obtained from many of the kinetic experiments. Whilst 
first order plots from simple solutions were essentially 
linear, non-linear results were obtained from most of 
the experiments which contained additives (e.g. Figs. 43, 
45, 51). This makes it much more difficult to reproduce 
the graph because the exact shape will be dependent on 
the sampling times. In addition, when apparent first
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order rate constants are calculated from the initial, 
linear, portion of such graphs, the value obtained will 
be strongly dependent on the number of data points used 
in the regression analysis. The number was always 
decided by visual assessment of the data but consistent 
results were obtained as demonstrated by the data for 
citrate-containing solutions (Section 2.12f, Table 25,
Fig. 43).
The reproducibility of the experimental data was con­
firmed by performing replicates of a few experiments at 
intervals throughout the work. The results are summarised 
in Table 37. Although the experiments for the first 
reproducibility study at pH 9 were all performed within 
one month, the time interval between some replicates 
was considerable and yet consistent results were still 
obtained. Figure 43 demonstrates the reproducibility of 
a distinctly non-linear result, the replicates in this 
case being performed two months apart. The statistical 
significance of the variation between replicates shown 
in Table 37 was tested in all cases by the student t-test 
(Appendix 1). In no case were the differences signifi­
cant at the 5% probability level.
Further support for the authenticity of the kinetic 
results was provided by the Arrhenius plots (Fig. 39).
The Arrhenius results at pH 9 show uod linearity and 
whilst those obtained at pH 7 have a lower linear corre­
lation coefficient, the deviations do not suggest major 
experimental errors.
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A potential source of error lay in the preparation 
of the salbutamol sulphate solution at the beginning of 
a kinetic run. The majority of the liquid was pre-equili- 
brated at the experimental temperature and then the req­
uired amount of drug was added as a concentrated solution. 
It was not possible to pre-equilibrate this solution 
because of the danger of initiating degradation too soon. 
This was a real problem because concentrated solutions 
were more susceptible to degradation than dilute ones 
(Fig. 36, Table 20). The long duration of each experi­
ment meant that it was not practical to keep a concentrated 
stock solution because it would not be used within a 
realistic time and so would have to be freshly prepared 
for each experiment. Therefore in order to avoid un­
necessary wastage of the drug, the exact amount needed 
for each particular experiment was weighed into a 10 ml 
volumetric flask and dissolved in water up to volume.
The resultant solution was added to the reaction vessel 
and complete transference of the drug was ensured by 
rinsing the flask with measured volumes of distilled 
water to bring the total in the reaction vessel to the 
required volume. Assay of the initial sample, which was 
withdrawn as soon as possible, confirmed the concentration 
of the reaction solution. Apart from a few early experi­
ments, the measured starting concentration was always 
within - 4% of the theoretical value.
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4.3 General factors affecting salbutamol sulphate stability
The kinetic studies commenced with a series of 
experiments designed to determine the major factors affect­
ing the stability of salbutamol sulphate solutions. This 
enabled later work to be performed under controlled 
conditions of concentration, temperature, pH etc. so 
selected that the maximum amount of relevant data could 
be collected in the time available.
Oxygen was soon shown to have a profound effect on 
the degradation of the drug. Solutions which were bubbled 
with the gas at 10 - 15 ml per minute followed apparent 
first order kinetics, semi-logarithmic plots being linear, 
unlike those obtained from unbubbled solutions which were 
sigmoidal (Fig. 34). The slopes of the lines from oxygen­
ated e:q)eriments were approximately 30% greater than the 
slope of the linear portion of the sigmoidal graphs. 
Increasing the oxygen flow rate to 50 ml per minute had 
no effect on the rate of salbutamol breakdown (Table 19) 
and so the solution must be effectively saturated with 
oxygen at the lower flow rate. It did not prove possible 
to use a sintered glass "bubbler" as the gas inlet 
because of the shortage of space within the flask.
However, these experiments suggest that adequate gas trans­
fer was able to take place even at the lower flow rate, 
using a fine glass tube as the inlet.
Since the oxygen flow rate was not critical, the 
exact rate used in each experiment was not measured
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precisely but always lay in the range 10 - 15 ml per 
minute as assessed by the bubbling rate. A higher rate 
was used in sugar solutions than in simple drug solutions 
because of their increased viscosity, which tended to 
hinder efficient mixing of the pH-stat titrant. The 
increase in agitation produced by a faster flow of gas 
improved the efficiency of the pH-stat control.
The importance of oxygen in the degradative mechanisms 
of salbutamol sulphate was demonstrated by the experiment 
in which high purity nitrogen replaced oxygen as the 
bubbled gas (Fig. 35, Table 19). The rate of breakdown 
was about three times slower than that under oxygen 
although it was still appreciable, the drug having a 
half-life of 70 hours at pH 9 compared to 25 hours under 
oxygen. The breakdown pattern observed on TLC plates 
was the same as that in oxygenated solutions and this 
implies that the degradation was due to incomplete removal 
of oxygen from the system. "White spot" nitrogen is 
claimed to contain no more than 5 ppm oxygen and this 
is unlikely to account for the degradation rate observed. 
However, if the solution contained residual oxygen when 
the drug was added at the beginning of the experiment, 
this could have been the cause of the breakdown. If this 
was the case, a fall in the rate constant towards the 
end of the experiment would be expected because the 
limited amount of oxygen would be used up in the reaction; 
such an effect was not observed. The most likely explanation
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is that small amounts of oxygen, either residual in the 
solution or introduced by the traces in high-purity 
nitrogen, initiate aut oxidation reactions. These are 
mediated by free radicals and are self-propagating, even 
when the initiator is no longer present. Catecholamines 
have been reported to be subject to autoxidation in the 
absence of oxygen. For example, adrenaline solutions stored 
under nitrogen have been shown to polymerise to form 
"adrenaline-black" or melanin (112), trace amounts of 
oxygen probably initiating the reaction. Free radical. 
mechanisms have frequently been postulated for catechdlamine 
oxidations (28, 30-32, 37, 110) and although salbutamol 
lacks the ortho-hydroxyl groups of a catechol, radical 
formation by the phenol would not be impossible. In 
oxygenated solutions the rate of reaction would be higher 
because initiation could take place constantly, but the 
reaction pathway would be the same, producing the same 
spectrum of breakdown products.
The concentration of the drug itself was found to be 
another major influence on the rate of degradation. Since 
oxidation reactions often appear to follow zero-order 
kinetics, dilute solutions are often stated to be more 
susceptible to such degradation than concentrated ones (23), 
because the percentage loss is greater. However, in the 
case of salbutamol, the more concentrated solutions were 
less stable than the dilute ones, as shown in Figure 36 
and Table 20, where it can be seen that the apparent first 
order rate constant increases with concentration. The
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implication is that oxidation is not the sole mechanism 
operating in the breakdown process and that although oxygen 
plays an important role in the degradation of the drug, it 
is not the rate limiting factor (Table 19).
It was also possible, since salbutamol is an ionisable 
molecule, that this concentration effect was simply due 
to changes in the ionic strength of the solution. Ionic 
strength has been shown to affect the degradation of 
several drugs (131-135) although in most cases the reactions 
concerned are hydrolytic. However there are a few examples 
of non hydrolytic mechanisms being influenced by ionic 
strength, an example of which is the degradation of 
chlorpromazine which is believed to be oxidative and 
mediated by free radicals (133). Experiments using a low 
salbutamol sulphate concentration at high ionic strength 
proved that this was not the important factor in this 
case (Fig. 38, Table 21) and that therefore the increased 
degradation rate in concentrated solutions is a function 
of the increased number of drug molecules present.
When the data were plotted according to the half- 
life method for the determination of reaction order 
(Equation 7) , the graph obtained (Fig. 37) was not com­
pletely linear, the half-life of the drug in 0.1% 
solution being approximately 10 hours (16%) greater than 
would be predicted from the other three data points.
Because of this, least squares regression analysis was 
applied to both the total data and to the data omitting
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the 0.1% result. The total data gave a reaction order of 
1.37 whereas that omitting the 0.1% data point gave an
order of 1.3 . In either case, the result confirms that
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the degradation is a complex process, probably involving 
several parallel, consecutive or opposing reactions (24-26). 
Experiments using drug concentrations such as 0.2% and 
0.4% would help to fill the gap in the half-life plot and 
determine whether there is a discontinuity. If there is, 
the fall in reaction rate in dilute solutions emphasises 
the importance of intermolecular reactions between drug 
molecules rather than solute-drug interactions.
Salbutamol has two functional groups which are 
capable of ionisation. These are the phenolic hydroxyl and 
the secondary amine and their pK^s at 25° are 9.35 and 10.3 
respectively (12). The three ionic species are shown in 
Figure 59 where it can be seen that salbutamol is always 
ionised, regardless of pH, due to the existence of a 
zwitterionic form. The proportion of each species present 
in solution at any given pH is depicted in Figure 60, 
where the shaded portion represents the region of the 
zwitterion. Although the pK^s are likely to shift with 
ten^erature, analogy with results published for pirbuterol 
(42) suggests that the phenolic pK^ will not alter signi- 
fica ntly between 25° and 70° and although the amino pK^ 
may fall by up to one pH unit, this will not result in 
the formation of a neutral species.










Fig. 59. The ionisation states of salbutamol
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Fig. 60. The ionisation of <=albutamol, the shaded area 
representing the zwitterionic form.
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of salbutamol degradation is greatest in the region of 
pH 9. This coincides with the region of maximum concen­
tration of zwitterion (Fig. 60) and therefore it may be 
inferred that the zwitterion is the least stable species. 
This conclusion is in agreement with that of Bansal and 
Mohkhouse (42) who examined the stability of pirbuterol, 
the pyridine analogue of salbutamol. The drug exhibited 
its lowest stability in the pH range 8-9, where, like 
salbutamol, it is zwitterionic.
Figure 40 shows that the relationship between log k 
and pH is approximately linear between pH S’ and pH 8 . 
However, the slope of this line is about 0.6 and so the 
degradation mechanism is not a simple base catalysed 
reaction which would have a slope of one. The maximum 
at pH 9 is believed to be real because the k value at 
pH 10 represents a 25% reduction on that at pH 9 and 
this is well outside the normal experimental variation in 
replicate studies (Table 37).
Although Figure 40 shows that salbutamol is most 
stable in the pH range 3-4, it was not possible to define 
this minimum because the rate of reaction was so slow 
that no detectable breakdown occurred during three months 
storage at pH 3.5 and 70°. The presence of this minimum 
cannot be explained on ionisation grounds as the molecule 
is fully protonated at the secondary amine in this region. 
Pirbuterol was not found to exhibit a minimum of this sort, 
the pH-profile levelling out to a plateau minimum below pH 2
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This difference can be explained if the principal 
mechanism of degradation for both drugs at acidic pH is 
by electrophilic attack. This characteristically takes 
place in acidic media but under these conditions the 
heterocyclic nitrogen atom in pyridine is protonated.
This has the effect of deactivating the ring to electro­
philic substitution as shown in Figure 61.
Q
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Figure 61. Stabilisation of the pyridinium ion.
The pyridine ionisation has a pK^ of about 3 in 
pirbuterol and so below pH 3 the drug will be extensively 
ionised, reducing the possibility of electrophilic attack.
In contrast, the benzene ring in salbutamol is not subject 
to this deactivation and will be more liable to react 
under increasingly acidic conditions, causing an upturn 
in the stability profile. The slope of this portion of 
the graph is also far removed from unity, being about 1.5. 
This indicates that the degradation is not a simple hydrogen 
ion catalysed reaction.
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The deactivating effect of the pyridine ring has a marked 
effect on the reactivity of pirbuterol over the whole pH 
range. At pH 8 and 90°, the drug has a half life of about 
6 days whereas salbutamol at pH 9 (the corresponding 
point of maximum breakdown) and 70° has a half-life of 
only 28 hours. Salbutamol is also much more sensitive to
pH than pirbuterol, the rate constant varying by a factor
3 *9 “1 —A — 1of 10 from 8.08 X 10 s at pH 3 to 6.94 x 10 s
at pH 9. The corresponding range for pirbuterol spans only
-8 -1a 33 fold variation from 4.47 x 10 s at pH 1 to 1.49 x
“6 "1 lO s at pH 8.
The fact that both drugs are always ionised would be 
expected to make them sensitive to ionic strength effects 
but this is not the case. Bansal and Monkhouse (42) report 
that preliminary experiments indicated that the breakdown 
of pirbuterol was affected by oxygen tension and buffer 
catalysis but not by ionic strength effects or light and 
similar results were obtained in this study of salbutamol. 
Equation (14), which is derived from the Bronsted and 
Bjerrum equations (24-26), predicts that at low concentrations 
and ionic strengths, the reaction between two ions should 
vary logarithmically with the square root of the ionic 
strength.
log = 1-02 (14)
where k = rate constant and k° = rate constant at infinite 
dilution
z^,z^ = charge on ions A and B and y = ionic strength
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At ionic strengths above 0.01 and up to 0.1, this equation 
is modified to equation (15)
log 5̂  = 1.02 — - 1^ ] (15)\ - z^z^ (
(l+6ti )
where $ is a constant, related to the ionic diameter of 
A and B. At even higher values of y, log k becomes 
proportional to ionic strength (136), even when the 
reacting species are uncharged.
The marked pH-dependence of the breakdown processes
of salbutamol suggests the involvement of ionic attacking 
— +species (OH and H ), and taken together with the ionic 
nature of the drug, would predict an ionic strength effect. 
The fact that ionic strength changes do not influence the 
rate of reaction implies that uncharged species such as 
solvent molecules, oxygen molecules or free radicals play 
a very important role. Equations (14) and (15) predict 
that reactions involving such species will be independent 
of ionic strength although, in these experiments, the 
conditions used fall outside the accepted limits for these 
relationships.
The reaction order of 1.3-1.4 calculated for salbutamol 
would suggest the involvement of free radical mechanisms 
which often have non-integral orders. The complex TLC 
patterns provide further confirmation of such a mechanism. 
Free radicals are highly reactive pecies and can therefore 
initiate several different degradative processes. This 
would explain the large number of compounds produced during
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the breakdown of salbutamol and would also account for the 
apparent similarity of the breakdown spectra under different 
conditions of pH (Fig. 41).
The oxidation of adrenaline and other catecholamines 
is also believed to proceed via free radicals (28, 37).
In contrast, however, pirbuterol was found to follow first 
order kinetics (42) and did not exhibit the concentration 
effect of salbutamol. TLC examination of degraded solutions 
revealed a much simpler pattern of breakdown in the pyridine 
derivative, only one degradation product being detected 
above pH 8. The evidence of the thin layer chromatograms 
and the first order rate dependence suggests that pirbuterol 
degrades by a simple mechanism at high pH. The mechanism 
at pH 8 and below is different because several breakdown 
products are produced but the pattern, nevertheless, is 
much simpler than that found in degraded salbutamol solutions.
Useful information about reaction mechanisms can often 
be gained from the temperature-dependence data when plotted 
according to the Arrhenius relationship (Equation 8 ).
Studies were carried out initially at pH 9.0, where the 
rate of salbutamol degradation is rapid, and later at pH 7.0. 
This latter pH was chosen because it lay on the linear 
portion of the pH-stability profile and was used for 
many of the subsequent experiments employing additives such 
as buffer salts and sugars. Degradation was slower than at . 
pH 9.0 but still fast enough for results to be obtained 
within realistic times.
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The graph at pH 9.0 displays good linearity but the
one at pH 7.0 appears, on visual inspection, to be sigmoidal,
the discontinuity being in the region 70° - 75° (Fig. 39).
However, least squares regression analysis of the data
gives a line which is parallel to that at pH 9.0 and
having a standard deviation to slope ratio of only 5.3%.
Discontinuities in an Arrhenius plot usually indicate a
change in reaction mechanism but the sigmoidal nature of
the graph is unusual, deviations usually being in a single
direction away from the expected linear relationship.
The activation energies, calculated from the regression
-1lines, were found to be 106.84 kJ mol at pH 9.0 and 
-1107.22 kJ mol at pH 7.0. These are in such close 
agreement, both having a coefficient of variation of 
less than 5.5% (Table 23), that it seems justifiable to 
treat the plots as linear. It would be useful to confirm 
this conclusion by obtaining additional data at inter­
mediate temperatures and by studying the temperature- 
dependence at other pH values.
The close similarity of the activation energies and 
the TLC patterns (Fig. 41) at both pH7.0 and pH 9.0 implies 
that the reaction mechanism does not change significantly 
with temperature or pH over the ranges studied. However, 
if the degradative process consists of a complex network 
of reactions, as suggested by the thin layer chromatograms, 
marked deviations from linearity would be expected. In 
such a system, each reaction would have an individual 
activation energy and temperature changes would therefore 
affect each reaction to a different extent, resulting in
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a change in the reaction mechanism. If the initial 
reaction is the rate limiting step, linear Arrhenius 
plots may be expected although differences in TLC patterns 
would probably still be apparent.
This situation is resolved if radical formation is 
the primary,rate limiting process under all conditions.
These radicals would then be able to react further by a 
number of routes, producing the variety of breakdown products 
detected. Such a mechanism is supported by the ionic 
strength results (Table 21), since radical formation is 
unlikely to be affected by ionic strength effects. An 
increase in salbutamol sulphate concentration would result 
in greater numbers of radicals which could, in turn, 
explain the increased degradation rate in more concentrated 
solutions.
Much of the later work on formulation excipients 
was conducted at pH 3.5, the region of minimum salbutamol 
sulphate degradation (Fig. 40). It would therefore have 
been useful to carry out an Arrhenius study at low pH 
(e.g. pH 3) in order to confirm that the primary reaction 
is not different from that at higher pH. However, the slow 
rate of reaction in simple salbutamol sulphate solutions 
at low pH put this beyond the scope of the present work 
but evidence from thin layer chromatograms suggests that 
no major differences would be found (Fig. 41).
It is not usually advisable to conduct Arrhenius-type
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studies at points of inflection on the pH-stability profile 
of a drug because more than one reaction mechanism is 
operating at this point and so the results are difficult to 
interpret. It is surprising that a good linear relation­
ship was found at pH 9 in the salbutamol study and this 
gives additional support to the theory of a common rate 
limiting step under all conditions. In their study of 
pirbuterol, Bansal and Monkhouse (42) , conducted Arrhenius 
studies at pH values where they predicted that a single 
ionic species would be present. These values coincide 
with inflection points in the pH profile of the drug and 
although they quote the activation energies so calculated, 
they give no indication of the linearity of the graphs 
obtained (Table 38).





Table 38. Activation energies for 0.5% pirbuterol 
solutions over the temperature range 
70° - 90° (42)
The activation energies for pirbuterol are significantly
“1lower than that obtained for salbutamol (107 kJ mol ) 
and again implies a difference in reaction mechanism 
between the two drugs, as confirmed by the difference in
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TLC patterns of degraded solutions of the two drugs.
The enthalpies of activation of adrenaline and other
catecholamines have been calculated by Beijeisbergen van
Henegouwen et al. (28). All were in the range 50 - 100 
— 1kJ mol , whilst Wall and Sunderland (41), using colori­
metric and fluorimetric assays, obtained a value of 
— 1134 kJ mol for the activation energy of salbutamol over
o othe temperature range 40 - 60 at both pH 2.4 and pH 7.1. 
This was reduced to 92 kJ mol at pH 8.3. They also found
that the Arrhenius plots were not linear above 60° and 
concluded that there must be a change in the reaction 
mechanism. No such change was detected in this study and 
the activation energy was found to be the same at both 
pH 7.0 and 9.0. These differences are almost certainly due 
to the spectroscopic assay methods employed and the buffer 
solutions used to control the pH in the earlier study.'
At the lower temperatures, degradation was considerably 
less than 50% and, in one case, less than 10% and so the 
validity of the calculated rate constant is questionable.
In addition to this, the first order plots, particularly 
at 70°, showed very marked deviations from linearity and 
yet the total data appears to have been used in the 
determination of the rate constant. It has been shown 
(Tables 12-15, Figs. 25-27) that the colorimetric assay 
seriously overestimates the salbutamol content of degraded 
solutions and this casts further doubt over the validity 
of the earlier study. However, since it has also been 
shown that phosphate accelerates the degradation of the drug
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(Table 25), the phosphate buffers used may have counter­
acted the errors in the assay!
Buffers have been found to affect the degradation 
of pirbuterol (42), carbuterol (44), adrenaline (45) and 
catecholamines (46) and so salbutamol may be expected to 
be similarly affected. The most common buffer effect is 
one of acceleration but retardation by specific inter­
action such as that between borate and catecholamimes (46) 
has also been reported. The stability of salbutamol 
sulphate solutions in the presence of citrate, phosphate 
and acetate was studiëd, all at pH 7.0 and a buffer con­
centration of O.IM. The results (Fig. 42, Table 25) 
reveal that acetate has a marked stabilising effect, re­
ducing the rate constant by about 30% whilst phosphate 
increases it to a similar degree. Although the acetate 
graph was linear, the phosphate line showed some sigmoidal 
character and the citrate plots were clearly non-linear. 
Figure 43 demonstrates that this non-linearity was 
a reproducible effect, the reaction rate slowing down 
when the residual drug concentration falls to 70% and then 
increasing again below 60% residual drug concentration.
The effect of this is that the overall rate of degradation 
in the presence of O.IM citrate is not markedly different 
from that in simple salbutamol sulphate solutions although 
the initial and final rate constants were approximately 20% 
greater. This result is difficult to explain because 
the pH was controlled by the pH-stat in these experiments 
and so the salts did not act as true buffers. Their 
degree of dissociation should therefore have remained
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constant and so deviations from linearity cannot be ascribed 
to changes in the ionic species present.
The degree of ionisation of an acid at a given pH 
may be calculated from its pK^ using the Henderson- 
Hasselbalch equation (16).
PH = pK^ + log (16)
The pK values (119) of the acids used in these experiments, 
together with their dissociation at pH 7.0 are presented 
in Table 39.
Acid Dissociation at pH 7
Acetic 4.8 Acetate:acid (160:1) 
3- 2-Citric 3.1,4.7,6.4 Citrate : citrate (4:1) 
3-Phosphoric 2.1,7.2,12.7 HPO^ : HgPO^ (0.6 :1)
Table 39. pK values of "buffer" acids and their a
dissociation at pH 7.
There does not appear to be a relationship between the 
degree of ionisation and the catalytic effect, if any, 
of the salt and so it must be concluded that the effects 
are specific to the ions concerned. The sigmoidal nature 
of the citrate results (Fig. 43) may be due to instability 
of the citrate ions. Caramélisation has been reported to 
occur when dextrose-citrate solutions are autoclaved (137) 
although this is less marked if citric acid is used instead
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of sodium citrate. The discoloration is probably primarily 
due to the sugar but the citrate activity is also reduced.
The graph obtained from the salbutamol stability experi­
ments containing citrate could be explained if citrate 
degradation occurs, resulting in a slowing of the salbutamol 
breakdown. Further citrate decomposition could form new 
products which accelerate the reaction again.Whatever the 
explanation of these effects, the results demonstrate the 
dangers of using buffer solutions to control the pH in 
stability studies without first assessing their specific 
actions. The stabilising action of some buffers could be 
used to advantage in the formulation of liquid dosage 
forms, provided they are physiologically acceptable.
Phosphate has been shown to have a catalytic effect 
on the anaerobic breakdown of carbuterol (44), but to 
inhibit the manganese-catalysed degradation of catechol 
and related compounds (46). This latter effect was 
presumably due to chelation and similar effects were 
observed with glycine, citrate and borate buffers (46). 
Chelation seems unlikely to explain the results obtained 
with salbutamol because it is not a characteristic of acetates, 
which stabilised the drug, but is of citrates and phosphates 
which had no stabilising effect. Experiments using diff­
erent concentrations of buffers would help to clarify the 
mechanism because an increase in buffer concentration would 
be unlikely to increase the effect if chelation of 
contaminating ions is the sole mechanism. However, if the 
buffer salt exerts a specific catalytic action, an increase 
in concentration should accentuate the effect. Additional
190.
evidence can be gained by examining the action of a 
powerful chelating agent such as EDTA.
Metal ions have been implicated in the oxidation of 
adrenaline (11, 34-36) but it is not certain whether they 
are essential for the initiation of the oxidation. Chaix 
et ai. (11) found that in the absence of added metal ions, 
the rate of oxygen uptake was low and proposed that this 
was due to trace contamination. However, cyanide, which 
forms strong complexes with copper, did not prevent the 
oxidation of adrenaline and, in fact, caused a slight 
increase in oxidation rate (37). Other workers (109) 
have shown that although EDTA reduces the catalysis of 
adrenaline breakdown by metals, the extent of its effect 
depends on both the catalyst and the buffer used. Metal 
ions, particularly copper, are known to catalyse salbutamol 
degradation (12) and so some kinetic experiments were 
conducted in the presence of 0.05% EDTA. This should 
chelate any metal ions present as trace contaminants 
and thereby prevent metal-catalysed degradation.
The results, which are presented in Table 26, resemble 
those of Sokoloski and Higuchi (37) in showing an increased 
rate of reaction in the presence of the chelating agent.
The implication is that the accelerating effect of phosphate 
could also have been due to chelation. Green et alt (38) 
observed a similar effect by ? xn on the rate of adrenaline 
breakdown. They showed that whilst iron alone did not 
alter, the breakdown, the iron-EDTA complex was a powerful 
catalyst. They drew a parallel with the biological.
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iron-containing catalysts of ferricytochrome and the 
ferritin complexes. In such systems the metal ion is 
held firmly in position, facilitating electron transfer 
during the catalytic process. A similar situation could 
exist with salbutamol but further work, involving the 
addition of metal ions to the reaction mixture is needed 
to confirm this.
Although the results discussed so far give indications 
of the probable routes of salbutamol degradation, con­
clusive evidence can only be obtained from the isolation 
and identification of breakdown products. Ideally, these 
compounds should then be assayed during kinetic experiments 
so that the relative importance of the various pathways 
and the existence of reactive intermediates can be esta­
blished. Attempts were made, therefore, to isolate the 
major degradation products of salbutamol. However, the large 
number of compounds generated during the breakdown results 
in low concentrations of each individual product. It 
was therefore possible to isolate only one compound in 
sufficient quantity and purity for further study. This 
compound ran on TLC with a Rf value of about 0.75 and 
represented the largest spot, after salbutamol in the 
thin layer chromatogram.
This compound eluted from the HPLC column after the 
internal standard, AH 4045, suggesting that it was con­
siderably less polar than salbutamol. Evidence from 
nuclear magnetic resonance spectroscopy (nmr) and mass
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spectrometry (Section 3) whilst not conclusive, indicates 
a dimeric structure in which one amino side chain has been 
lost, as shown in Figure 55. It is possible that some of 
the other TLC spots represent higher polymers which eventually 
produce the yellow-brown precipitate which formed in ex­
tensively degraded salbutamol sulphate solutions.
Although polymeric products are formed as a result of 
adrenaline oxidation (29-31), the intermediates are indole 
derivatives, resulting from cyclisation of the cate­
cholamine molecules. The reaction (Fi-g. 62) is believed to 
proceed via a semi-quinone radical which is rapidly 
oxidised further to an open-chain quinone (28, 30, 31, 37). 
This in turn probably undergoes oxidative intramolecular 
cyclisation to the corresponding aminochrome. It is 
possible that leucoadrenochrome (Fig. 62) is formed as an 
intermediate in the reaction (30, 31) but since it would 
rapidly lose water to form the 5,6-dihydroxyindole or 
be oxidised to adrenochrome, this mechanism is not certain. 
This reaction mechanism has been applied to many catechol 
derivatives including DOPA (110) and noradrenaline (30), 
and also to phenylephrine (39).
The aminochrernes are highly coloured compounds and 
the formation of adrenochrome is the cause of the pink 
colour acquired by adrenaline solutions which are exposed 
to the air. However, they do not represent the end of the 
degradative process but can participate in polymerisation 


















Fig. 62. The oxidation of adrenaline.
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that the first step is a dimérisation which is acid catalysed. 
The dimer can then react further to produce the polymeric 
melanin (Fig. 63).
^ melanin
Fig, 63. The formation of melanin from adrenochrome
Bu'Lock believed the propagation reaction to occur between 
the dihydroxyindolyl group and the indoquinone of the mono­
mer or other oligomers.The precise composition and 
structure of the polymer is variable, being dependent on 
the reaction conditions. Although the.polymerisation can 
proceed in the absence of oxygen as shown by Harley-Mason 
(112), the product has a greater pyridine solubility, 
presumably due to a lower molecular weight or greater 
number of phenolic hydroxyls (111).
Although degraded salbutamol solutions formed a 
precipitate, this varied in colour from yellow to brown, 
unlike melanins which are typically dark brown or black 
(32). The proposed structure of the major decomposition
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product (Fig. 55) suggests that, unlike catecholamines, 
salbutamol does not undergo intramolecular cyclisation 
to any significant extent. This is probably because 
salbutamol, by lacking the catechol group, cannot form 
an ortho-quinone which is a vital intermediate in the 
formation of aminochromes and the subsequent melanins 
(Fig. 63). The single phenolic group in salbutamol 
also results in a less highly activated ring, which would 
therefore be less sensitive to substitution reactions. 
However, when TLC plates of solutions which had been exten­
sively degraded at high pH were examined under ultra-violet 
light, a small fluorescent blue spot was sometimes observed. 
It has been shown that sane 5,6-dihydroxyindoles have a 
weak blue fluorescence (30) and so it is possible that 
the indole derivative of salbutamol is formed in small 
quantities under these extreme conditions but the reaction 




Possible structure of the indole derivative of salbutamol
salbutamol loss.
The steric hindrance resulting from the bulky tertiary 
butyl group in salbutamol is also likely to cause differences 
between its reactions and those of the catecholamines. All
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the natural catecholamines have small nitrogen substituents, 
being either primary amines (e.g. noradrenaline) or methyl 
substituted secondary amines (e.g. adrenaline), and so 
little hindrance is likely during the cyclisation reaction.
An alternative degradation pathway has been proposed 
for the sympathomimetic phenylephrine (75). The stability 
of this drug was studied at pH 6.8 and the workers con­
cluded that the principal breakdown products resulted from 
a Pictet-Spengler reaction between the drug and formalde­
hyde generated during the degradation. The scheme they 
proposed is outlined in Fig. 64 and shows initial oxidation 
of the drug leading to the production of formaldehyde.
This then reacts with further phenylephrine molecules to 
ultimately form isoquinoline derivatives.
Svensson (74) examined the stability of terbutaline, 
a bronchodilator similar in structure to salbutamol, 
and concluded that the Pictet-Spengler reaction constituted 
a minor degradation pathway. The major degradation 
product was identified as 1-(3,5-dihydroxyphenyl)-2- 
tertbutylimino ethanol, the result of a relatively simple 
oxidation.
HCH,NHCM e. -------- — ----- >
HO' HO
Terbutaline \ y " Ç H C H = N C M e ,















oxidation products oxidation products
Fig. 64. The degradation of phenylephrine by the 
Pictet-Spengler reaction.
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Bahsal and Monkhouse, in their study of pirbuterol 
(42), also investigated the possibility of a Pictet-Spengler 
reaction. They added excess formaldehyde to a pirbuterol 
solution at pH 6 and examined the resultant solution by 
TLC. A new spot was observed in a position which did not 
correspond to any of the usual decomposition products and 
so they concluded that the pathway was not important in 
the normal breakdown of the drug.
Both phenylephrine and terbutaline have hydroxyl 
groups meta to the amino side chain. The mechanism of 
the Pictet-Spengler reaction, as depicted in Fig. 64 
involves intramolecular electrophilic attack by the 
substituted amine. Since phenolic groups activate the 
ortho and para positions to such attack, both these drugs 
are candidates for the reaction. The lower reactivity 
of terbutaline, in spite of the dual activation by the two 
phenolic groups, is probably due to steric hindrance by 
the tertiary butyl substituent on the nitrogen atom. 
Salbutamol and pirbuterol are not able to cyclise in 
this way at an activated position on the ring because the 
phenolic groups are para-orientated to the side chain.
These compounds are therefore unlikely to undergo the 
reaction and further discouragement to intramolecular 
reaction is provided by the tertiary butyl nitrogen sub­
stituent.
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4.4 The effect of sugars on the stability of salbutamol 
sulphate solutions
Although much more work is needed to establish the 
details of the salbutamol decomposition reactions, the 
influence of formulation excipients on the rate of break­
down can still be examined. Such studies are important 
during the formulation and develojxnent of a drug when the 
chemistry of the compound may still be under investigation.
Sugars were the principal excipients to be examined, 
since these are major ingredients in pharmaceutical syrups 
and have been shown to influence the degradation of some 
drugs (13, 16, 64-69). Fig. 44 shows that at pH 7.0,
10% glucose increased the degradation rate of salbutamol 
sulphate by a factor of 2 but sucrose had no effect at 
all. Fructose was not examined at this pH because the 
Lobry de Bruyn-van Ekenstein rearrangement (Section 1.6) 
results in the interconversion of glucose, fructose and 
mannnose and so a solution of any one of these will, in fact 
be an equilibrium mixture of the three.
At pH 3.5, the region of maximum salbutamol stability
in simple solutions, 50% glucose, fructose and sucrose
increased the breakdown to similar extents (Fig. 45)
resulting in initial apparent first order rate constants
-7 -1in the range of 4 to 5 x 10 s . Reduction'of the
sucrose concentration to 10% caused a fall in the rate
-8 -1constant to 5.47 x 10 s and in the absence of sugars, 
no detectable breakdown of salbutamol occurred over a
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similar time period (800 hours), as shown in Figure 4 6.
The eight-fold increase in rate constant for a five-fold 
increase in sugar concentration indicates that the reaction 
order is greater than unity with respect to sucrose, but 
since the residual sugar concentration was not measured 
during these experiments, precise determination of the 
order was not possible.
It was surprising to find that the sugar concentration 
had such a pronounced effect on the rate of salbutamol 
degradation. Even at a concentration of 10% the mono­
saccharide molarity (O. 56 M) greatly exceeded that of 
the drug (O. 015M) and so would be expected to swamp the 
reaction which would then proceed at the maximum rate.
The acceleration of salbutamol breakdown is unlikely to 
be due to changes in the dielectric constant, caused by 
the sugars, because sucrose would then be expected to 
be as effective as glucose and fructose at all pH values. 
Sugars reduce the dielectric constant of water and thus 
inhibit ionisation of solutes and ionic interactions.
This parameter has been shown to affect reactions such 
as ester hydrolysis (135) but, like ionic strength, is less 
likely to affect reactions involving uncharged species. 
Changes in the dielectric constant would therefore not 
be expected to be the primary reason for the loss of 
stability of salbutamol sulphate in sugar solutions.
The results from the experiments using 50% sugar and 
citrate buffer at pH 3.5 showed that the buffer has little
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effect on the rate of drug breakdown during the early stages 
although some stabilisation may occur once the residual 
drug concentration has fallen below 70% (Fig. 48). This is 
in keeping with the results obtained at pH 7.0 using 
citrate alone (Fig, 43), where it was noted that a reduction 
in the rate of reaction took place between 70% and 60% 
residual drug. The rate increased again below 60%, an 
effect which was not observed when 50% sugar was used with 
the citrate but this may have been masked by the sugar 
effects since even in the absence of citrate the rate of 
reaction decreased markedly as the drug concentration fell 
(Fig. 48). This slight stabilisation by citrate is of 
little practical significance in pharmaceutical formulation 
because it only manifests itself when considerable break­
down has already taken place. The aim in formulation is 
to devise a product which will degrade by no more than 10% 
during its shelf-life and so this citrate effect is of no 
apparent use.
The most significant feature of these experiments 
using sugars is the pH-dependence of the sucrose effect 
and this can be explained by considering the structure of 
the sugar. Sucrose is a disaccharide formed by a glyco- 
sidic linkage between a glucose unit and a fructose unit, 
as described in Section 1.6. This link involves the 
carbonyl group of both monosaccharides and is quite stable 
in neutral or alkaline solutions (57, 114). However, under 
acidic conditions hydrolysis occurs, liberating the con­
stituent monosaccharides, glucose and fructose (113).
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Equation (17) has been developed by Vukov (114) to 
describe the rate of sucrose hydrolysis under varying 
conditions of temperature, pH and concentration.
log k = 16.91 + log (d-c) - - pH (17)
-1where k = hydrolysis rate constant (min )
-1d = density of solution (g ml )
-1c = sucrose concentration (g ml )
T = temperature
This equation was used to calculate the extent of sucrose 
hydrolysis under the experimental conditions, and the 
results are summarised in Table 40.
Conditions k (min )̂ Half-life
50% sucrose pH 3.5 5.08 X 10 23 hours
10% sucrose pH 7 4.56 X 10 2.9 years
Table 40. The rate of sucrose hydrolysis under varying 
conditions of pH and concentration at 70^
The effect of this difference in hydrolysis rates is 
profound since at pH 7.0, less than 0.1% hydrolysis will 
occur during the course of the experiment (250 hours) at 
70°. However, the more rapid reaction at pH 3.5 means 
that the sugar will be extp sively hydrolysed at an 
early stage of salbutamol breakdown as illustrated in 
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Fig. 65. Comparison of hydrolysis rate of sucrose (dotted line) 
with degradation rate of salbutamol sulphate (A) in 
solution containing 50% sucrose and 0.5% salbutamol
sulphate at 70 and pH 3.5.
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is therefore dependent on the hydrolysis of the sugar 
to its constituent monosaccharides. These differ from 
the disaccharide in having a potentially "free" carbonyl 
group in their open chain or acyclic form. The drug-sugar 
interaction may therefore take place at this carbonyl 
which in sucrose is absent^ being used in the formation 
of the glycosidic bond.
The differences between the effects of the sugars, 
which became apparent after approximately 300 hours at 
70° and pH 3.5 (Fig. 45) are probably due to differences 
in the stability of the sugars themselves. The reaction 
rate in the presence of fructose slowed down more quickly 
than in the presence of the other two sugars and may 
reflect the greater tendency of fructose to form furan 
derivatives (58, 113).
The samples from all the sugar experiments, except 
that of sucrose at pH 7.0, showed an additional peak in 
the HPLC trace with a k' value of approximately 0.4 
(Fig. 47). This implied that the increase in the degradation 
rate was due to an additional specific reaction between 
the drug and the sugar resulting in a new breakdown 
product. TLC examination of the degraded solutions re­
vealed an additional spot at high Rf in the samples from 
experiments at pH 3.5 (Fig. 66). At pH7.0 the picture 
was not so simple because the drug had degraded extensively 
by the normal routes and the resultant spectrum of breakdown 

















Sulphate pH 3.5 pH 7.0
Fig. 66. Diagrammatic TLC plate of a standard 0.5% salbutamol 
sulphate solution, together with samples degraded in 
the presence of glucose at pH 3.5 and pH 7.0 at 70 .
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66). This did not happen at the lower pH because the 
degradation of salbutamol sulphate in simple solution at 
this pH is so slow that spots due to these reactions were 
very small, the major degradation being due to the 
sugar interaction.
Interactions between glucose and ammonia or amines
have been reported on several occasions (121-125), the
products usually being glucosylamines. Mitts and Hixon
(12L) prepared several glucosyl-n-alkylamines by heating
o
the sugar and amine .at 70 with 0.5N hydrochloric acid.
These conditions are similar to those used in the kinetic 
experiments with salbutamol and mildly acidic conditions 
have also been used by Japanese workers to prepare the 
N-glucoside of sulphanilamide (127). They used a pH of 
3-4 and found that the yield of glucoside was much greater 
when the concentration of sugar exceeded that of the amine. 
Although most workers have used simple primary amines, 
secondary amines are reported to give similar products 
(126), the reaction often being slower in these cases. 
Glycosylamines hydrolyse quite readily (121-123), the ease 
of reaction being related to the basicity of the amine (121) 
Both dilute acids and alkalis can catalyse the hydrolysis, 
their relative effectiveness being dependent on the com­
pound in question (123). A different compound, deoxyfructo- 
sazine has been isolated as a product of the reaction 
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H
Deoxyfructosazine
The mechanism of the reaction between sugars and 
amino acids has been studied by Namiki and Hayashi (125) 
using electron spin resonance spectroscopy (ESR). Although 
sugar solutions alone did not produce free radicals, addition 
of amino acids to the solutions caused radical formation.
The conclusion was that radicals are developed early in 
the amino-carbonyl reaction and the suggested structure 
was that of an enaminol, resulting from the rearrangement 
of the glycosylamine.
R ' - C - C - N - R  R = amino acid residue
OH H R'= sugar residue
In order to test this hypothesis that the carbonyl 
is the site of interaction between sugars and salbutamol, 
glyceraldehyde, a simple,non-volatile aldehyde was studied.
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The result, depicted in Figure 51, indicated a lag phase 
followed, after approximately 50 hours, by a rapid accel­
eration of the degradation. This implies that the aldehyde 
is not active as such but requires a preliminary reaction 
before it can exert an effect on salbutamol. In their 
studies on sugars and amino acids, Namiki and Hayashi 
(125), were able to detect radicals immediately but 
chemical reaction, indicated by browning of the reaction 
mixture, often took longer to become apparent. It.is 
possible that in the reaction between salbutamol and alde­
hydes, time is needed for the free radicals to accumulate 
to a concentration which will initiate reaction. Such a 
lag phase has been observed in the oxidation of catecholamines 
and ascribed to the formation of radicals (28). Once 
the highly reactive radicals have reached the "critical 
level", a chain reaction is initiated and loss of drug 
becomes apparent. This lag phase was not observed in the 
experiments with sugars but this could be due to their 
greater concentration (50% instead of 5%) which would 
enable radicals to be generated more quickly. However, 
this higher concentration of excipient would also increase 
the possibility of a radical reacting with a sugar 
molecule instead of the drug and this could explain the 
slower loss of salbutamol from such solutions, compared to 
that from the glyceraldehyde solution.
An alternative possibility is that the glyceraldehyde 
is oxidised to glyceric acid which then reacts with 
salbutamol. Consequently, a similar experiment using
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glyceric acid instead of glyceraldehyde was performed. 
Although the results from this experiment revealed a rapid 
loss of salbutamol during the early stages of the reaction 
(Fig. 51), the rate fell dramatically after about 50 hours 
when about 70% salbutamol sulphate remained. It is most 
unlikely that this represents depletion of the glyberic 
acid because the 5% (0.47 M) concentration used was 
greatly in excess of that of the drug (O. 015 M). Oxidation 
of glyceraldehyde to glyceric acid is therefore probably 
not the mechanism of its reaction with salbutamol.
Glyceraldehyde can form a dimer by intermolecular 
acetal formation (61) but the resultant compound has a
cyclic structure analogous to that of the hexoses.
CH,OH Ç H P H
H C — CHO H 0  CH(OH)
H OH ^-----------  O Oi
O H C -C H  (HO)HC------ OH
CKOH inpn'2
2 glyceraldehyde dimer
It has already been shown that the hexoses do not react 
with salbutamol when the carbonyl group is unavailable, 
as in sucrose, and so the glyceraldehyde dimer is not a 
credible intermediate in the salbutamol reaction.
However, another compound obta' lable from glyceraldehyde 
is methylglyoxal, the production of which from glyceral­
dehyde has been shown to be catalysed by amines (128, 129).
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CHO ÇHO
CHOH -------- > CO
CHPH CH,
Glyceraldehyde Methylglyoxal
Methylglyoxal is a highly reactive compound and polymerises 
readily (129). If formed in the reaction mixture con­
taining salbutamol it would therefore be a likely inter­
mediate in salbutamol breakdown and would account for the 
rapid loss of drug after an initial induction period.
None of the proposed mechanisms for the aldehyde- 
drug reaction explain the effect of glyceric acid, 
however.. The evidence points to depletion of the active 
compound but since the acid itself is present in such 
excess, a contaminant seems to be indicated. Approximately 
30% of the salbutamol sulphate in the solution was used 
in the reaction, which represents a concentration of 0.15%.
-20.15% salbutamol sulphate = 0.446x10 M 
5% glyceric acid = 0.472 M
Assuming that the contaminant reacts 1:1 with salbutamol 
sulphate, on a molar basis,the contamination level would 
need to be:
- ' % M 2 - -  ̂  = 0-94%
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Since the glyceric acid was not of Analar grade, a purity 
level of 99% seems quite reasonable and so the reaction 
with salbutamol need not have involved the excipient under 
examination. The nature of the possible impurity is not 
clear from these results. No lag phase was detected and 
so glyceraldehyde is unlikely to be the responsible 
component but further work is needed to identify alternatives.
Since neither the aldehyde grouping, nor its oxidation
derivative, the carboxylic acid appeared to be directly
responsible for the degradation of salbutamol, alternative
mechanisms were examined. Sugars are themselves subject
to degradation, particularly at alkaline pH (115) 5-hydroxy-
methylfurfural (5-HMF) being a characteristic product
(58, 59, 106-108), together with various organic acids (54,
116, 117) and lower molecular weight sugars (118). The
effect of concentration on the rate of glucose decomposition
appears to vary with the temperature used. Zheltukhin (117)
found the rate constant in aqueous solution to be independent
oof concentration at 167 but to increase with the concen­
tration at 186°. He ascribed this increase to autocatalysis 
by formic acid, a breakdown product at these extreme 
temperatures. Webb et.al. (107) using temperatures around 
100°, showed glucose solutions to be more stable at higher 
concentrations. If this is the case, and the loss of 
salbutamol is due to sugar decomposition products, the 
rate of drug loss should not be markedly affected by the 
sugar concentration. It was shown though, that the dis­
appearance of salbutamol was much slower in the presence
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of 10% sucrose than in the presence of 50%.
Having demonstrated from the experiment with glyceric 
acid (Section 2.12k) that carboxylic acids are unlikely 
intermediates in the reaction, the only decomposition 
product likely to have a significant effect was 5-HMF.
This is a reactive compound which is believed to polymerise 
readily and to be responsible for much of the discolouration 
of degraded sugar solutions (58, 59, 120). It is produced 
by the dehydration of the sugar molecules, usually under 
acidic conditions and its appearance has been used to 
follow the decomposition of glucose solutions (59, 107,
108). Nevertheless, the amount of 5-HMF produced by glucose 
is quite small (59) although greater yields are obtained from 
fructose solutions (58, 113). If the sugar-initiated loss 
of salbutamol is mediated by 5-HMF, greater loss would 
therefore be expected from fructose solutions than from 
glucose or sucrose solutions. Figure 45 shows however, 
that there were no significant differences in the initial 
rates, and that beÿond approximately 35% degradation, 
salbutamol was more stable in the presence of fructose 
than in glucose or sucrose solutions. These results 
therefore do not lend support to this theory. However, in 
order to resolve the question, 5-HMF was tested at concen­
trations likely to result from the degradation of sugar 
solutions and was found to have no effect on the rate of 
salbutamol breakdown, as illustrated in Table 30. This 
provides further evidence that a carbonyl group is not 
the sole requirement for the sugar-drug interaction.
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It appeared, therefore, that the acceleration of sal- 
butamol breakdown by sugars is not due to sugar decomposition 
products,-,nor to a direct reaction between the sugar carbonyl 
and the drug. It seemed unlikely that a reaction occurs 
between the sugar hydroxyls and the drug because sucrose 
did not accelerate salbutamol degradation until hydrolysed 
although hydroxyl groups are available for reaction in 
the ddsaccharide. The hydroxyl group in 5-HMF is also 
very reactive (120) but this compound had no detectable 
effect on the rate of salbutamol breakdown. However, in 
order to establish the role, if any, of this functional 
group in salbutamol degradation, the polyhydric compounds 
propylene glycol, glycerol and sorbitol were studied under 
various conditions.
All three excipients increased the rate of salbutamol 
degradation but to varying extents. Propylene glycol and 
glycerol were used at a concentration of 10% at pH 7.0 
and the initial rate of breakdown in both cases was faster 
than that in a simple salbutamol sulphate solution at pH 
7.0 (Fig. 49). In the case of the dihydric. alcohol, 
the rate constant was increased by more than 100% at first 
but this fell after approximately 50 hours and then approxi­
mated to that in a simple solution. Like the glyceric 
acid result, this cannot be due to depletion of the main 
component because it is present in great excess over the 
drug. However, small amounts of impurities may be responsible 
for the initial rapid loss of drug, the rate of which was 
slightly greater than that resulting from the addition of
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10% glucose (Table 27).
The rate in the presence of the trihydric alcohol, 
glycerol, did not display this tendency to fall dramatically 
after a relatively short time. The increase in the rate 
constant was less than that obtained in the presence of 
glucose, being approximately 33% over that for a simple 
solution and was constant throughout the experiment, suggesting 
a reaction between salbutamol and glycerol rather than an 
impurity in the excipient.
The HPLC traces revealed an additional peak in both 
solutions but TLC examination was inconclusive because of 
the masking effect of the normal degradation products, as 
occurred with sugar solutions at pH 7.0. The product formed 
in the presence of propylene glycol eluted from the HPLC 
column between salbutamol and the internal standard but 
the glycerol reaction product eluted so close to salbutamol 
that it was only resolved when applied to a column of higher 
plate number. This order of elution reflects the greater 
polarity of glycerol, with three hydroxyls, over propylene 
glycol with two. This trend was continued in the studies 
using 50% polyhydric alcohol (sorbitol) at pH 3.5. The 
sorbitol reaction product eluted even earlier, before 
salbutamol, in a similar position to that from the hexose 
solutions but having a slightly higher capacity factor 
(1.0 instead of 0.4). The additional peak in the glycerol 
solution at pH 3.5 was in the same place as that at pH 7.0. 
being barely separated from salbutamol. The presence of
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a new compound in these solutions was confirmed by TLC 
examination of the solution at pH 3.5 when an extra spot, 
well separated from salbutamol, was clearly visible.
The kinetic results at pH 3.5 (Tables 28 and 29) 
revealed that the polyhydric alcohols and the sugars are 
similar in their effects on salbutamol degradation although 
the initial rate constant from the sorbitol experiment was 
statistically different from those obtained in the presence 
of sugars. Since the graphs are all curved (Figs. 45 
and 50), the significance of initial rates is equivocal 
because they are dependent on the number of data points 
selected in their calculation. The similarity of the effects 
of sugars and polyhydrics under these conditions is 
surprising in the light of the previous evidence concerning 
sugars; the lack of sucrose effect at pH 7 (Fig. 44) 
suggesting that hydroxyl groups, and therefore polyhydrics 
would have little effect on salbutamol degradation.
Although the reaction mechanisms may differ between the 
two classes of compound, the similarity of the rate constants 
and the appearance of a peak in the HPLC traces of the 
sorbitol solution, comparable to that from sugar solutions, 
implies that the reactions are closely related, if not 
identical.
Kitson et ai. (16, 17) have postulated the oxidation 
of polyhydric alcohols to reducing sugars in order to 
explain their effect on the stability of a triazolo- 
pyrimidine derivative. They found that whilst methanol and
216.
acetone had no effect on the degradation rate of the drug, 
acetaldehyde and reducing sugars markedly increased the 
rate of decomposition. The polyhydric alcohols, mannitol 
and sorbitol, were effective only in the presence of 
oxygen and solutions of these alcohols which had been 
heated at 100° for a few days gave positive results with 
Fehling's reagent, indicating the presence of reducing 
compounds. The decreased stability of the drug in the 
presence of reducing sugars was ascribed to the formation 
of Schiff bases (Section 1.7).
During the studies on salbutamol stability it was 
noted that solutions of salbutamol sulphate, both alone 
and in the presence of sugars, discoloured markedly as 
degradation proceeded, usually resulting in the formation 
of a yellow-brown precipitate. Sugar solutions discoloured 
particularly quickly, presumably due to decomposition of 
the sugar itself. However, in the presence of polyhydrics 
the solutions remained colourless, even when the residual 
salbutamol sulphate concentration had fallen to less than 
50%. This implies that extensive oxidation of the polyol 
to reducing sugars, as suggested by Kitson et ai. (16, 17) 
does not take place, since the sugars so formed should 
degrade in the normal way.
The only way to be certain of the nature of the degradation 
products formed in the presence of syrup excipients is to 
isolate and identify them. Attempts by the methods described in 
Section 2.7, to isolate the adduct produced by the reaction
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with glucose resulted in a compound- whose nmr spectrum 
was.virtually the same as that of salbutamol. When sub­
jected to thin layer chromatography the compound ran as 
salbutamol, having an Rf of about 0.6 instead of the 
previous 0.85. The conclusion drawn from this was that 
hydrolysis of the adduct had taken place during the 
extraction and purification process. If the compound was 
a glucosylamine, evidence from published data (121-123) 
indicates that hydrolysis would take place readily and so 
careful isolation procedures would be necessary to maintain 
its integrity. However, the ease of hydrolysis may also 
mean that the reaction between the drug and glucose is 
of little pharmacological significance. If this took 
place in a pharmaceutical product, such as an oral syrup, 
and yet the salbutamol was liberated in the gastro-intestinal 
tract, the bioavailability of the formulation may not be 
affected.
The reaction in the presence of 50% glyceml at pH 3.5 
resulted in a compound which was more stable and could be 
isolated successfully. The analysis of the nmr spectra 
of the compound is described in Section 3, and a possible 
structure is depicted in Figure 57.
4.5 Conclusions
This work has served as an introduction to the stability 
of salbutamol sulphate solutions, indicating the major 
factors influencing the stability of the drug but, as yet.
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unable to fully explain the effects or propose mechanisms 
for the drug's reactions. The work was hindered to some 
extent by the slow rate of degradation under some conditions 
which precluded the replication of many experiments. A 
particular example is the experiment at pH 5.0 using a 
drug concentration of 0.5% at 70°, performed during the 
investigation of the pH-stability profile (Table 24). After 
running for 450 hours this experiment had to be stopped 
because of a water bath malfunction and an opportunity to 
repeat it did not arise. The rate constant obtained is 
therefore based on only 10% degradation of the drug and 
is thus subject to a greater degree of uncertainty than 
those which were obtained from more extensively degraded 
solutions. The use of higher temperatures would reduce the 
time needed for each experiment but introduce the possibility 
of initiating atypical reactions which do not represent 
those prevailing at more normal temperatures.
Non-isothermal methods allow the temperature to be 
increased over the course of the experiment, reducing the 
time needed and these may prove useful in the study of 
salbutamol sulphate. However, the Arrhenius plot at pH 7.0 
would need to be checked first because a linear Arrhenius 
relationship is necessary if non-isothermal methods are to 
produce valid results.
Further work which is suggested by the results obtained 
so far include an Arrhenius study at about pH 3, near the 
region of maximum salbutamol sulphate stability and therefore
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the region of formulation. The influence of metal ions and 
chelating agents appears to require further investigation 
in order to explain the unusual behaviour of EDTA in 
accelerating the decomposition of the drug. Similarly, 
the effects of buffer salts could be examined at different 
concentrations to establish whether their action is exerted 
via chelation or direct catalysis.
One of the most interesting aspects of this work was 
the effect of sugars on the breakdown of the drug. The 
absence of an accelerating action by sucrose at pH 7.0 
suggested at first that this might be a better pH for the 
syrup formulation than the current one of 3.5. However, 
even in the presence of 50% sugar at pH 3.5, the rate of 
salbutamol degradation is less than that in a simple 
solution at pH 7.0. Further investigation of the concen­
tration dependence of the sugar effects would be useful 
since it is likely that a limiting value is reached somewhere 
between 10% and 50%, the only two concentrations examined 
so far. An Arrhenius relationship in the presence of sugar 
would also be of value and may help in establishing the nature 
of thé drug-sugar reaction.
Additional work on sugar chemistry, particularly that 
relating to the oxidation of polyhydric alcohols would 
help to explain the action of these compounds on the rate 
of breakdown of the drug. The disaccharide, maltose, 
would provide further evidence relating to the requirement 
for a "free" carbonyl in the salbutamol-sugar interaction.
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This sugar, unlike sucrose, has only one carbonyl bound 
into the glycosidic link and if studied at pH 7.0 would be 
expected, frcxn the evidence so far, to accelerate the 
degradation of the drug. At pH 3.5 maltose, like sucrose 
is hydrolysed to its constituent monosaccharides.
Finally, development of expertise in isolating and 
identifying the major breakdown products is needed. The 
results obtained in this study were disappointingly 
inconclusive and further purification of the isolated 
materials is needed in order to identify them with any 
degree of certainty. The reactivity of the compounds 
require the mildest possible conditions to be used at 
all stages of their isolation if further decomposition 
is to be prevented.
4.6 Pharmaceutical Implications
Since this work was concerned with the stability 
of aqueous solutions of salbutamol sulphate and the effect 
of formulation excipients on this/ it would be useful 
tO'make some tentative predictions of the shelf life of 
salbutamol products. A:ll the work was conducted at temper­
atures far in excess of normal storage conditions and in 
many cases the pH was not pharmaceutically realistic for 
reasons of experimental convenience. However, some cautious 
extrapolation of the results is possible.
oFrom the pH-stability profile of the drug at 70 (Fig.
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40), the rate constant at pH 3.5 is predicted to be approx- 
-9 -1imately 6.0 x 10 s . Assuming that the same Arrhenius 
relationship holds at this pH as at pH 7 and 9, then, from 
equation (8)
E
log k = log A - 2T3§35^
-E
log k^g - log k^^ = ( J:______L-)\ 298 343 /
—9 —107x10^ —4log _ log (6.0X10 ) = (4.4x10 )
log k^5 = -2.46 - 8.222
= -10.682
-11 -1 . k^^ = 2.08 X  10 s
tio % = 249L
9= 5.07 X  10 s
= 163 yrs
It would seem therefore that a 0.5% solution of salbutamol 
sulphate at pH 3.5 would be perfectly stable under normal 
storage conditions.
The safety margin at this pH appears to be more than 
adequate and so formulation at a higher pH, nearer to 
physiological values should be possible. If a shelf-life 
of three years is selected then,
0.105k25 36 X 30 X  24 x  3600
"9 " 1k^^ = 1.13 X 10 s
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-E
log k__ - log k25 ^  70 2.303R -I L.)298 343)
log k^Q = log (1.13 x 10 + 2.46
log k^^ = 2.46 - 8.95
k^^ = 3.26 X  10  ̂s ^
From Fig. 40, such a rate constant would result from 
formulation at about pH 6. Since oxygen was found to 
markedly increase the degradation rate of the drug (Table 
19, Fig. 35), the shelf life could be extended by packing 
the solution in ampoules under a gas such as nitrogen.
If a similar calculation is performed, this time with 
the more tenuous assumption that the activation energy 
for the drug-sugar reaction is the same as that for the 
degradation in simple solution, an estimation of the shelf- 
life of the oral syrup may be made.
= 4.81 X lo"^ s”  ̂ (Table 28)
-7 -107x10^ -4log k^g - log (4.81 x 10 ') = 2.3'o^R )
log k^^ = -2.46 - 6.318 
= -8.778
- 9 -1 k__ = 1.67 X 10 s25
^10%
0.105
= 6.3 X  10^ s
= 24.3 months
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A syrup formulation containing 0.5% salbutamol sulphate 
would therefore be predicted to have a shelf-life of 
barely two years.
Obviously these extrapolations are highly unreliable 
and much more work would be needed to produce more relevant 
data but they serve to illustrate at least, the profound 
effect formulation excipients can have on the shelf-life 
of a drug.
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APPENDIX 1 STATISTICAL METHODS
Least squares regression analysis
If two variables x and y, bear a linear relationship to each
other, the best way of determining the equation of the straight line
is by least squares analysis. This fits the best line through a
set of points by minimising the sum of the squares of the deviations
of the points from the line. The general equation of the line is
y = a + bx and the values of a and b may be determined from the
following formulae:
b = z (x-x)(y -y )I(x-X)2
a = y - bx
where y and x are the mean values of y and x respectively.
The correlation coefficient, r, is a measure of how well the data 
fit a straight line relationship and may be determined from the 
formula:
Z(x-x)(y-y)
/ - 2  :/2 /Z(x-x) Z(y-y)




where = Ze^ and e = y - (a + bx) 
n-2
The variance of a,
-2
X
—  2 Z(x-x)
The standard deviations of a and b are equivalent to the square 
root of the variance. Details of the derivation of these formulae 
may be found in standard statistical texts (140).
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Student's t-test
This is used to cemparé two estimates of a parameter, p^ and p^, 
having standard deviations and respectively. The value of t 
is calculated according to the formula:
P^-P2
This value is then compared with tabulated values of t (141) having 
N-4 degrees of freedom where N is the sum of the number of 
observations used in determining p^.and p^.
If the calculated value of t exceeds the tabulated value at the 
5% probability level, the two estimates are considered to be 
significantly different.
Bartlett's Test
This is similar to Student's t-test but is used when more than 
two estimates of a parameter are being compared.
%(p. - P)^
B =  r------
°2
where
’"‘I'̂ l ■ "2''2 ..... n'̂ nn,a? + n„a^ + ...n
°2 = n. + n_ ...n 1 2  n
p^, p^ are the estimates of the parameter, having standard deviations 
0^,0^ etc. respectively and n^, n^ etc. are the numbers of observations 
used in making each estimate of p.
B will have a distribution if the estimates of p cone from
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a normal distribution and so the calculated value of B may be 
compared with tabulated values of (141)having n-1 degrees of
freedom. (N is the number of estimates of p) . As with t, if the 
calculated value exceeds the tabulated value at the 5% probability 
level, the estimates of p may be considered to differ significantly.
227.
Appendix 2. Slopes of HPLC calibration lines over the course of a year
Date Slope Date Slope Date Slope
4.1.79 10.12 27.6.79 9.11 19.10.79 8.94
8.1 10.21 4.7 9.72 23.10 8.83
29.1 10.26 17.7 9.91 25.10 9.01
19.2 10.79 25.7 10.01 29.10 9.09
21.2 10.28 26.7 10.33 30.10 9.08
22.2 10.54 31.7 10.00 1.11 9.00
27.2 11.38 1.8 10.46 6.11 8.89
5.3 9.26 2.8 10.25 8.11 9.07
12.3 9.45 14.8 10.38 13.11 9.20
13.3 9.27 15.8 10.29 16.11 8.88
14,3 9.52 31.8 9.06 20.11 9.20
21.3 9.15 3.9 9.18 22.11 8.87
26.3 9.51 4.9 9.20 26.11 9.38
28.3 9.40 20.9 9.22 27.11 8.77
5.4 9.86 25.9 9.64 29.11 9.28
2.5 10.18 27.9 8.97 30.11 9.38
8.5 9.73 2.10 9.01 7.12 9.03
22.5 9.57 5.10 9.10 14.12 9.18
30.5 9.24 9.10 9.23 19.12 9.18
4.6 9.13 12.10 9.10
26.6 8.88 16.10 9.18
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